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Abstract
Congenital heart defects (CHDs) are the most common human birth defect and the
leading cause of death from a birth defect in the first year of life. Thus, a further
understanding of the mechanisms underlying CHDs, which could lead to improved diagnosis
and treatment, is crucial. The small GTPase, Rac1, acts as a pleiotropic effector of numerous
cellular processes; however, little is known about its role in embryonic heart development.
The aim of this thesis was to investigate the role of Rac1 signaling in cardiac development.
Using the Cre/loxP system, mouse models with an anterior second heart field (SHF) or
ventricular myocardium specific deletion of Rac1 were generated. I demonstrated that mice
with a SHF Rac1 deficiency displayed a spectrum of CHDs including bifid cardiac apex and
septal defects. These Rac1 deficient cardiomyocytes failed to undergo polarization. In
addition, migration and lamellipodia formation was disrupted in Rac1 deficient
cardiomyocytes. Decreased SHF Rac1 signaling led to increased apoptosis and
downregulation of several cardiac developmental transcription factors. Furthermore, my data
showed that organization of anterior SHF progenitors was disrupted, leading to a spectrum of
outflow tract (OFT) defects in Rac1 deficient mice. Cardiomyocytes with a Rac1 deficiency
failed to polarize and undergo myocardialization, causing misalignment of the OFT. At P0,
Rac1 deficient aortic valves displayed defects in maturation and remodeling and intrauterine
echocardiography performed at E18.5 showed severe aortic valve regurgitation. Finally, I
showed that a Rac1 deficiency in the ventricular myocardium resulted in ventricular
noncompaction and defective trabecular development. The myocardium proliferation rate
was significantly decreased and expression of the planar cell polarity protein, Scrib, was
reduced. Actin polymerization was severely disrupted and cardiomyocytes failed to polarize
in E18.5 Rac1 deficient ventricular myocardium. In conclusion, my thesis is the first to show
ii

that Rac1 signaling regulates several pathways, including proliferation, cell survival, gene
expression and actin polymerization during embryonic heart development. Through these
mechanisms, Rac1 is a critical regulator of cardiomyocyte polarity, septal and OFT
development and formation of the ventricular myocardium.

Keywords: Rac1, cardiomyocyte polarity, congenital heart defects, heart development, cell
organization, migration, outflow tract, second heart field
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Chapter 1 Introduction

1.1 Heart Development
The heart is the first organ to form and function in all vertebrates and is critical in
ensuring proper nutrient and oxygen supply to the developing embryo. Heart
development is a complex, highly regulated and multi-stepped process of myogenesis and
morphogenesis where populations of progenitor cells must merge in a temporally and
spatially coordinated fashion. The heart develops from three distinct populations of cells:
the first heart field (FHF), second heart field (SHF) and neural crest cells. FHF
progenitors originate from the anterior lateral plate mesoderm and form two lateral heart
fields along the midline. The two heart fields will then coalesce and form a crescent
shape in the anterior embryo by E7.5 in the mouse. At approximately E8.0, the FHF cells
merge along the ventral midline to form the primitive beating heart tube. The heart tube is
made up of an interior layer of endocardial cells and an outer layer of myocardial cells
with extracellular matrix in between the two layers. This tube undergoes rightward
looping by E9.0 and begins early chamber morphogenesis.1 SHF cells originate from
pharyngeal mesoderm and lie anteriorly and medially to the FHF cardiac crescent. As the
heart tube forms, SHF cells migrate into the midline and lie dorsal to the heart tube. Upon
rightward looping of the heart tube, SHF cells cross the pharyngeal mesoderm and are
added progressively into the arterial and venous poles of the heart tube, differentiating
into myocardial, endocardial and smooth muscle cells of the outflow tract (OFT), future
right ventricle (RV), atria and interventricular septum.2-5 As well, following looping
morphogenesis, endocardial cushions will begin to form within the OFT and the
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atrioventricular canal (AVC), which will later help septate the common OFT and divide
the heart into four chambers (Figure 1.1).6 SHF progenitors have elevated rates of
proliferation and differentiation delay with respect to the FHF cells that contribute to the
heart tube.7 The SHF also expresses distinct genes that distinguish it from the FHF
including the growth factors Fgf10 and Fgf8 and the transcription factors Tbx1, Islet1
(Isl1) and Mef2c.8-13 Compared to the SHF, the FHF is difficult to locate due to the lack
of distinguishing markers.2 Along with the SHF progenitors, neural crest cells migrate
from the neural tube and contribute to the remodeling and septation of the OFT, which
will become the aorta and pulmonary artery of the heart.14 By E15.5, the embryonic heart
structure is mostly complete except for the semilunar and atrioventricular valves, which
will continue to undergo remodeling and maturation after birth.15

Figure 1.1. Heart development in the mouse.
Oblique views (top panels) and frontal views (lower panels) of cardiac progenitor cells in
the embryonic mouse. FHF progenitors form a cardiac crescent by E7.5 and will merge to
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form the primary heart tube by E8.0. SHF progenitors will migrate into the heart tube to
elongate the arterial and venous poles. After rightward looping of the heart tube, cardiac
neural crest (CNC) cells will also migrate into the OFT to contribute to cardiac
development. V, ventricle; A, atrium; CT, conotruncus; RA, right atrium; LA, left atrium;
AS, aortic sac; RV, right ventricle; LV, left ventricle; AVV, atrioventricular valves; Ao,
aorta; PA, pulmonary artery; DA, ductus arteriosus; RSCA, right subclavian artery; RCA,
right carotid artery; LCA, left carotid artery; LSCA, left subclavian artery. Figure adapted
with modifications from Srivastava, D. Cell. 2006;126:1037-1048.

1.1.1 Second Heart Field
The existence of extra-cardiac progenitor cells that contribute to later formation of
the OFT myocardium was first suggested in 1977 by de la Cruz et al.16 The question of
where the OFT myocardium originated from remained unclear until 2001 when three
different groups published reports of a separate population of cells that contribute to the
initial heart tube in both chick and mice.9, 17, 18 In one initial chick study, a group of cells
called “secondary heart field” was found adjacent and posterior to the OFT region while
in the other chick study, the newly discovered group of cells was termed “anterior heart
field” and encompassed a larger region of the cranial pharyngeal mesoderm extending
into the pharyngeal arches.17, 18 In mice, Kelly et al. discovered a population of anterior
heart field cells, which expressed lacZ under the control of Fgf10 regulatory elements in
the splanchnic and pharyngeal mesoderm, contributing to the RV and myocardial cells at
the arterial pole of the heart tube.9 A later study on the LIM homeodomain transcription
factor Isl1 found this region of the murine anterior heart field to be actually more
extensive, extending more posteriorly and contributing to elongation of both the arterial
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and venous pole of the heart tube. Thus, the SHF is subdivided into an anterior and
posterior domain where the anterior region is marked by the Fgf10-lacZ transgene while
Isl1 marks both domains.9, 13
A complex network of signaling pathways and transcription factors regulate the
SHF progenitor cell population in the dorsal pericardial wall as it proliferates and
progressively differentiates in the OFT. One example is retinoic acid signaling, which
plays a role in defining the posterior boundary of the SHF progenitor cells and later on in
differentiation of the distal OFT progenitor cells.19 Fibroblast growth factors (Fgf),
including Fgf3, Fgf8 and Fgf10, play a part in regulating the high rate of SHF progenitor
cell proliferation in the dorsal pericardial wall.20 Upstream of this, Wnt/β-catenin and
Notch signaling regulate the expression of FGF ligands.21 Studies have shown that
conditional loss of Fgf, Wnt/β-catenin and Notch signaling in the SHF leads to a
shortened OFT and OFT defects.20, 22, 23 In addition, Hedgehog (Hh) signaling has been
demonstrated to be critical for SHF progenitor cell proliferation by acting through the
transcription factor, Tbx5.24 Numerous other transcription factors play critical roles in the
SHF including Isl, Tbx1, Six1, and Eya1, which regulate FGF expression, proliferation
and cell survival of progenitor cells.25-27 As SHF cells migrate into the heart tube,
proliferation decreases and there is an onset of myocardial differentiation. Bone
morphogenetic protein (BMP) signaling at the distal OFT promotes differentiation of
SHF cells by antagonizing FGF signaling.28 Together with BMP signaling, SHF
progenitors residing proximal to the heart tube will initiate expression of Gata4, Nkx2.5,
Tbx20, Mef2c and Hand2 to activate the myocardial gene expression program.18
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Mef2c is a member of the myocyte-specific enhancing factor 2 (Mef2) family of
MADS-box transcription factors, which has been shown to be critical for cardiac
development. There are four Mef2 genes in vertebrates: Mef2a, Mef2b, Mef2c and
Mef2d,29 which bind a conserved A-T rich DNA control region associated with cardiac,
skeletal and smooth muscle lineages.30 Mef2c is one of the earliest markers of the cardiac
lineage at E7.5 and precedes expression of α-cardiac actin, a sarcomeric protein. Strong
Mef2c expression in the developing heart continues from E7.5 to E11.5 and then begins
to decline.30 Mef2c-/- mice have a SHF phenotype where the heart fails to loop, the OFT
has gross abnormalities and the RV does not develop.10 Dodou et al. discovered an
enhancer and promoter from the Mef2c gene that was expressed exclusively in the
anterior heart field during cardiac development.11 Subsequent fate mapping studies using
Cre expression under the control of the Mef2c anterior heart field promoter and enhancer
(Mef2c-AHF-Cre) show that lacZ expressing cells mark progenitors of the SHF that
contribute to formation of the RV, ventricular septum and the endothelial and myocardial
cells of the OFT.31 Thus, the Mef2c-AHF-Cre is the first transgenic mouse line with Cre
activity restricted to the anterior heart field and its derivatives, making it an excellent tool
for genetic studies in the SHF. Hence, this Mef2c-AHF-Cre transgenic mouse line was
used to study the SHF in Study 1 and 2.

1.1.2 Neural Crest Cells
Neural crest cells are a multipotent population that migrates from the dorsal
neural tube during embryonic development to contribute to numerous tissue types
including the peripheral nervous system, melanocytes and tissues of the head and neck.3234

Early transplantation and cell labeling experiments in avian models identified a specific
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region of the dorsal neural tube that contributed to parts of the heart and associated
vessels.35 Following these observations, subsequent chick studies showed that ablation of
the neural crests in the cranial region before the cells became migratory led to a failure of
the common OFT to divide into aorta and pulmonary trunk, abnormal patterning of the
aortic arch and great arteries, OFT alignment defects and VSDs.36 Since these seminal
discoveries in the chick embryo, this population of neural crest cells has been termed
“cardiac neural crest” due to their importance in heart development. Subsequent studies
in transgenic mouse models using neural crest promoters have confirmed the importance
of the cardiac neural crest in cardiovascular development that was first observed in avian
models.37, 38 Cardiac neural crest cells delaminate from the neural tube at approximately
E8.5 in the mouse, migrate and pause in the circumpharygeal ridge before migrating into
and populating pharyngeal arches three, four and six as each arch forms.39 These neural
crest cells play a critical role in repatterning of the pharyngeal arches to become the great
arteries of the thorax, including common carotid, aortic arch and ductus arteriosus.40
Additionally, a subpopulation of cardiac neural crests from the pharyngeal arches will
migrate into the OFT cushions at approximately E9.5 to form the aorticopulmonary
septation complex, which will divide the common outflow tract into the aorta and
pulmonary trunk.41 Development and remodeling of the semilunar valves (aortic and
pulmonary valves) also rely on tissue-tissue interactions between the cardiac neural crest
and the SHF cells.42 As neural crest cells migrate into the developing heart, they are
closely juxtaposed to migrating SHF progenitors in the pharyngeal mesenchyme where
they are able to influence each other through various signaling mechanisms. Defects in
SHF progenitors or the cardiac neural crest cell population can have secondary effects on
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the other cell type, supporting an intricate relationship between these two cell types in
cardiac development.43-45

1.1.3 Development of the Septated Heart
From E8.25 to E10.5 in the mouse, the heart tube will undergo rightward looping,
which is the first event displaying left-right asymmetry during embryonic development.
As looping proceeds, the RV and left ventricle (LV) become arranged side by side and
connected to the common OFT. The distance between the atrial and venous poles shorten
as they converge and the ventricular bend will shift caudally. In the late stages of looping,
the proximal OFT will shift to the left and the heart tube will undergo ballooning of the
atrial and ventricular regions. The OFT undergoes remodeling and the aortic valve
becomes wedged between the AV valves.46 As looping morphogenesis occurs, SHF
progenitors are concurrently being added into the heart tube to subsequently give rise to a
majority of the RV, interventricular septum and OFT. A failure of SHF cells to
incorporate into the heart tube can interrupt cardiac looping.13 As the heart completes
looping, it will undergo a septation process through growth of myocardium and valve
development and remodeling to form a four-chambered heart.
Separation of the atria from the ventricles occurs through development of AV
valves (mitral and tricuspid valves), which originate from AV endocardial cushions
formed at E9.0. The AV endocardial cells undergo a process of EMT and the cushions
will remodel and gradually maturate to form thin, valve leaflets. During this process of
remodeling and maturation, the mesenchymal cells will proliferate and extracellular
matrix (ECM) deposition will extend the cushions to form the valve leaflets.
Development of the AV valves is dependent on numerous signaling factors secreted by
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the myocardium underlying the cushions, including BMP, TGFβ and Vegf. These factors
will promote EMT of the endocardial cushion.47 In addition, the endocardial cells also
express receptors for Nfatc1 and Vegf, which are critical for valve development.48, 49 The
semilunar valves (aortic and pulmonary valves) arise from the conal and intercalated
cushions in the OFT. The right and left leaflets of the semilunar valves are formed from
the conal cushions.50 The intercalated cushions will develop into the posterior aortic and
anterior pulmonic leaflets.51 Similar to development of the AV valves, OFT conal
cushions undergo a process of EMT to give rise to mesenchymal cells that proliferate,
followed by matrix deposition, elongation and remodeling/thinning of the valve leaflets.52
Development of the semilunar valves requires similar signaling pathways, transcription
factors, epigenetics and morphogenetic events as those required for AV valve
development.53
Besides development of cardiac valves to septate the heart, the atrial and
ventricular chambers must also undergo septation to divide it into their left and right
counterparts. The muscular part of the interventricular septum is formed between the two
future ventricles from ballooning of the apical components. This muscular septum will
continue to grow superiorly towards the AV cushions, leaving an opening at the AV
canal between the two ventricular chambers. This opening will be closed by the
membranous part of the interventricular septum that develops from the AV cushions.54, 55
Tbx5 has been shown to be essential for determining LV identity and the interventricular
boundary. Overexpression of Tbx5 in mice causes expansion of the LV and loss of the
interventricular septum.56 Compared to ventricular septation, atrial septation is a more
complex process. A muscular septum, called the primary atrial septum, begins to grow at
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E9.5 from the atrial roof towards the AV cushions. The edge of the primary septum
contains a mesenchymal cap. Growth of the primary septum will partially septate the
atrial chamber, leaving an opening called the ostium primum that allows shunting of
blood between the two chambers.57 The mesenchymal cap will fuse with the AV cushion
and the dorsal mesenchymal protrusion (DMP), which is mesenchymal tissue from the
dorsal mesocardium, to close the ostium primum. As this occurs, apoptosis occurs on the
anterior side of the primary septum to create a second opening called the ostium
secundum, which is later closed by the muscular secondary atrial septum.55

Many

signaling pathways and transcription factors are critical to atrial septum formation
including BMP signaling and the GATA and TBX family of transcription factors.58-60
Septation of the heart is dependent on interactions between different cardiac cell
lineages, including the SHF and cardiac neural crest cells. Besides complex signaling
mechanisms that exist within each lineage, progenitors of each lineage interact with other
cells to coordinate the septation process. Lineage tracing studies show that a large part of
the interventricular septum is derived from SHF progenitors.61 The DMP that contributes
to atrial septum is also derived from SHF progenitors.62,

63

Many studies have

demonstrated that disruption of several different signaling pathways in the SHF result in
defective septation of the heart. For example, disruption of calcineurin/Nfatc1 signaling
in the SHF led to increased apoptosis, regression of OFT cushions and a subsequent
absence of semilunar valve formation.64 Hedgehog and BMP signaling is essential for
development of the DMP for atrial septation.65, 66 In addition, deletion of the transcription
factor Hand2 or disruption of BMP4 signaling in SHF progenitors lead to defects in
interventricular septum formation in mouse embryos.27, 67
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Cardiac neural crest cells have roles in OFT septation and development of the
semilunar valves as well, with little to no contribution to AV valve development.6 These
cells are crucial for remodeling and maturation of the semilunar valves and formation of
the aorticopulmonary complex to septate the OFT.42, 68 Cardiac neural crest cells will also
interact with surrounding tissues, such as the SHF-derived OFT myocardium through
semaphorin signaling to migrate into the developing OFT. Specifically, the semaphorin
Sema3c is expressed in the SHF-derived OFT myocardium and signals to PLXNA2
receptors expressed on migrating cardiac neural crest cells.69

1.1.4 Ventricular Myocardium Development
Maturation of the ventricular chamber myocardium is essential for increased
cardiac output as an embryo grows and develops. The ventricles grow and mature
through a process of proliferation and differentiation to form trabeculation and the
compact myocardial layer. In general, cardiac chamber maturation can be divided into
three processes: formation of trabeculae, formation of conduction system and thickening
of the compact myocardium.70 Trabecular formation begins in the mouse at
approximately E9.5 where cardiomyocytes grow to form protrusions of muscular ridges
that become lined by invaginating endocardial cells. As these ridges form, the trabecular
projections grow and spread radially to form a network of trabeculation. This formation
of trabeculation facilitates oxygen and nutrient exchange in the heart and enhances force
generation during contraction.71 The trabeculae then undergo a process of remodeling or
compaction where growth stops and the spaces between trabeculae become capillaries.
The bases of trabeculae thicken and collapse into the myocardial wall. By E14.5, a
mature trabecular network is formed, along with formation of a thick, compact
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ventricular myocardium.72 A gradient of decreasing proliferation and increasing
differentiation exists from the compact myocardium zone towards the trabecular zone.
Proliferation of the compact myocardium is concomitant with remodeling of the
trabeculation.73 Signaling from the endocardium and epicardium to myocardial cells have
been demonstrated to be critical for trabeculation and ventricular development. For
example, neuregulin 1, produced by endocardial cells, act on receptors in the
myocardium to regulate trabecular development.74 The cardiac jelly between the
endocardium and myocardium plays a crucial role in transmission of signals between
these two cell types.75 In addition, FGF signaling from the epicardium to myocardial cells
has been demonstrated to be a critical regulator of ventricular wall development.
Interestingly, endocardial-derived signals seem to regulate trabecular development while
epicardial-derived signals seem to mediate compact myocardium development.76
Numerous signaling pathways have been implicated in maturation of the cardiac
ventricular chambers including Notch, ephrin, BMP, FGF, retinoic acid and ECM
signaling pathways. In addition, biomechanical forces such as sheer stress can influence
signaling pathways that regulate chamber maturation. However, the relationship between
these physical forces, gene expression and chamber development is not well
understood.70

1.1.5 Outflow Tract Development
In early development, the cardiac OFT forms at the arterial pole of the heart tube,
connecting the ventricles to the aortic sac. The OFT is composed of an outer myocardial
layer, derived from the anterior SHF, and an inner lining of endocardial cells. As the
primitive heart tube undergoes rightward looping, SHF progenitors will migrate
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progressively from the pharyngeal mesoderm to elongate the heart tube and contribute to
the myocardial layer of the OFT, which reaches its maximal length by E10.5.2 As the
heart tube grows, the AV canal, future atrial and ventricular septa and the developing
OFT will align with the ventricles, facilitating proper septation of the heart.
Abnormalities in this convergence process often cause major OFT defects.77 The OFT
also undergoes a wedging process where it rotates in a counterclockwise direction,
putting the aortic valves behind the pulmonary trunk and to the left to align between the
two AV valves. Abnormalities in the wedging process leads to misalignment of the OFT
with the ventricles and failure to complete development of the interventricular septum.78
As SHF progenitors add to the early OFT, proliferation markers are downregulated and
early markers of the myocardial lineage are upregulated.79 The early OFT is divided into
two parts: conal/proximal region, which is adjacent to the RV, and the truncal/distal
region, which is adjacent to the pharyngeal arches. These two regions of the OFT have
distinct characteristics and the boundary between the truncal and conal parts plays crucial
roles in remodeling.53
Cardiac neural crest cells are involved in numerous events of OFT development
including remodeling of the pharyngeal aortic arches, truncal cushion development,
formation of the smooth muscle cell layer and reciprocal signaling to the SHF to regulate
SHF proliferation and deployment.36, 80 As the truncal portion of the OFT forms, cardiac
neural crest cells will delaminate from the neural tube at approximately E9.0, migrate
into the caudal pharyngeal arches and colonize the truncal OFT cushions. These cardiac
neural crest cells, together with fusion of the truncal cushions of the OFT, will give rise
to the aorticopulmonary septation complex by E11.0.81 The septation complex will form a
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shelf-like structure distal to the OFT, between the fourth and sixth aortic arches, growing
towards the proximal OFT and fusing with the conal OFT cushions to septate the
common OFT. As the same time, the OFT undergoes counterclockwise rotation and shifts
to become aligned above the future ventricular septum. The conal cushions also fuse to
divide the proximal OFT into right and left ventricular outlets.

51, 82

The proximal outlet

septum becomes muscularized through myocardialization, a process where myocardial
cells grow and migrate into the flanking mesenchymal tissue. By E14.5, OFT remodeling
and septation is complete and the aorta is connected to the LV and pulmonary artery is
connected to the RV.83

1.1.6 Transcription Factors in Heart Development
Transcriptional activity and gene expression during heart development is a tightly
controlled process, involving cascades of interacting transcription factors. A transcription
factor has sequence-dependent affinity for specific DNA motifs to regulate transcriptional
activity of numerous downstream target genes. A core group of transcription factors can
interact with each other or function as biochemical partners in a complex transcriptional
network to regulate each step of heart development.84, 85 Some key cardiac transcription
factors and the most well studied to date include TBX5, NKX2.5 and GATA4. Based on
the multifaceted transcriptional interactions and synergistic regulation of numerous
pathways by transcription factors, it is not surprising that a mutation in any one of the
core transcription factors has been shown to cause inherited or sporadic congenital heart
defects (CHDs) in humans.86-88
One of the first transcription factor genes identified to be associated with inherited
CHDs was TBX5. Humans with a heterozygous mutation in TBX5 have Holt-Oram
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syndrome, which include defects in upper limb and heart development, specifically atrial
septal defects (ASDs), ventricular septal defects (VSDs) and conduction defects.88, 89 In
mouse studies, TBX5 has been shown to regulate interventricular septum formation and
development of the conduction system.90,

91

Mice with a TBX5 null mutation have

developmental arrest by E9.5, the heart tube fails to loop and the embryos do not survive
past E10.5. It was shown that TBX5 and NKX2.5 interact to regulate synergistic
transcriptional activation of atrial natriuretic peptide (ANP) and connexin-40 (Cx40)
genes.92 Along with that, TBX5 and NKX2.5 interact in a transcriptional cascade to
regulate development and maintenance of the cardiac conduction system.93
Mutations in the NKX2.5 gene were the first single-gene defect linked to nonsyndromic CHDs in humans. Mutations in the NKX2.5 gene have been shown to cause
inherited ASDs, atrioventricular block, VSDs, Ebstein’s anomaly and Tetralogy of Fallot
(TOF).94,

95

NKX2.5 deficient mice are embryonic lethal by E9.0 due to defects in

looping morphogenesis of the heart tube.96 Although commitment to the cardiac lineage
is not compromised in NKX2.5 deficient mice, expression of several cardiac genes is
reduced including ANP, myosin light chain 2v (MLC2v) and Hand1, indicating that
NKX2.5 functions near the top of the transcriptional cascade to regulate numerous
cardiac genes essential for myocardium development beyond the looping stage.96-98 In
addition to interactions with TBX5,92 NKX2.5 has also been shown to interact directly
with GATA4 and another transcription factor, serum response factor (SRF), to promote
cardiac sarcomeric protein expression.99
The zinc finger transcription factor GATA4 is one of the earliest transcription
factors expressed in the developing mouse heart beginning at E7.5 and continues to be
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expressed throughout adulthood where it maintains normal cardiac function and acts to
protect the heart from stress-induced heart failure.100-103 Studies in mice where GATA4
expression levels were reduced in varying degrees showed that GATA4 is a dosagesensitive regulator of heart development. A graded reduction in GATA4 expression
resulted in mice with a common AVC, double outlet right ventricle (DORV) and
hypoplasia of the myocardium.104 Mutations in the GATA4 gene cause inherited ASD and
VSDs in humans, as well as dilated cardiomyopathy in later life.105 Like the other core
transcription factors, GATA4 acts in a synergistic manner with other transcription
factors, such as Smad4 and Mef2 proteins, to regulate valve development and expression
of cardiac genes.106, 107 In addition, GATA4 functionally interacts with TBX5 to activate
expression of Cx30.2, a gap junction protein highly expressed in the AV node.108
In addition to these core transcription factors, TBX5, NKX2.5 and GATA4, other
notable transcription factors that are discussed in this thesis include the basic helix-loophelix (bHLH) transcription factor Hand2 and TBX20. Hand2 is highly expressed in the
developing RV and Hand2-/- mice are embryonic lethal by E10.5, displaying RV
hypoplasia and vascular defects.109-111 Along with its previously mentioned interactions,
NKX2.5 also interacts with Hand2 and Mef2c to regulate ventricular identity.112, 113 The
Hand factors, Hand1 and Hand2, function in a dose-sensitive manner to regulate cardiac
development and gene expression.114 Hand2 maps to chromosome 4q33, where
duplications or mutations have been associated with a range of septal and OFT defects.115
In a cohort of patients with defects in the RV and OFT, 5% had mutations in the Hand2
gene, making it a strong candidate gene related to CHDs.116 TBX20 is expressed in both
the FHF and SHF and acts as a dose-sensitive regulator of OFT, valve and RV
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development.117,

118

TBX20 acts to repress TBX2 in the outer curvature to establish

regional patterning of the myocardium during development and functions to maintain
adult heart function. TBX20-/- mice fail to undergo heart tube looping and chamber
formation does not occur.119, 120
Research in the past two decades has rapidly uncovered an intricate cardiac
transcriptional network involving numerous transcription factors that is beyond the scope
of this thesis. Although the importance of these transcription factors in heart development
have been established, few downstream targets have been identified that can explain the
precise cellular mechanisms for CHDs. Further research to identify the specific targets
downstream of the associated transcription factors will be crucial for understanding
normal heart development and the pathogenesis of CHDs.121

1.2 Congenital Heart Defects
Congenital heart defects (CHDs) are abnormalities in the structure and function
of the heart that arise during embryonic development. It is the most common human birth
defect, affecting up to 5% of live births and it is the leading cause of death from a
congenital malformation in the first year of life in industrialized nations.122,

123

Tremendous advances in diagnostics, surgical techniques and medical care have
increased the survival rate of CHD patients in the last 60 years. Due to these
improvements in care, the population of adult CHD patients has grown rapidly and is
now estimated to outnumber the childhood population 66% to 34%, respectively, in
Canada.124 However, adult patients can face ongoing health and disease burdens
throughout their lives including multiple re-operations, arrhythmias, bacterial
endocarditis and heart failure, which are major causes of morbidity and mortality.125 Our
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current understanding of the etiology of CHDs is still limited as only 20% of cases can be
attributed to a known cause.126 CHDs can be linked to genetic or environmental factors,
or a combination of both. Some environmental factors include maternal alcohol
consumption, use of therapeutic drugs, and maternal illnesses and conditions such as
diabetes and rubella infection.127 Genetic factors include chromosomal disorders like
trisomy 21, deletion syndromes such as DiGeorge Syndrome or single gene disorders like
Holt-Oram caused by TBX5 mutations.128 Despite much progress in our understanding of
heart development, the cellular and molecular mechanisms underlying CHDs are still not
fully understood. A further understanding of the intricate developmental mechanisms
regulating cardiogenesis is critical for potential future advancements in diagnostics,
prevention and treatment of CHDs.

1.2.1 Atrial and Ventricular Septal Defects
Holes that exist between the atria or ventricles and allow mixing of oxygenated
and deoxygenated blood between the two chambers are defined as septal defects. When
accounting for all the different types of CHDs, defects in ventricular and atrial septation
are one of the most common types, with reported prevalence of 30.7% for VSDs and
11.6% for ASDs.129 A VSD can occur in either the muscular or membranous part of the
ventricular septum, with membranous VSDs occurring more frequently.122 VSDs can also
occur as an isolated cardiac defect or as part of a complex CHD, such as TOF and
transposition of the great arteries. ASDs can be divided into two major types: ostium
primum or ostium secundum defect. If the primary atrial septum or the secondary atrial
septum fails to form properly, an ostium secundum defect occurs. If the ostium secundum
defect is large, it may lead to right atrial overload due to left-right shunting and cause
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complications such as atrial fibrillation and pulmonary hypertension.130 Ostium primum
defect is less common but more severe compared to ostium secundum defects. This
defect is an incomplete septation between the inferior margin of the primary atrial septum
and arises from abnormal growth of the primary septum or development of the
endocardial cushions.131 Like other CHDs, the etiology of atrial and ventricular septal
defects is complex and multifactorial. As described above, mutations in cardiac
transcription factors TBX5, NKX2.5 and GATA4 are associated with VSDs and ASDs in
humans. Functional interaction of these cardiac transcription factors is critical for septal
development.88,

94, 105, 132

Besides a genetic factor, environment influences such as

pregestational diabetes and teratogens are associated with septation defects in the fetus.127
Moreover, numerous mouse studies have shown perturbations in SHF progenitor
signaling pathways can lead to ASDs and VSDs, since the SHF is a major contributor of
these cardiac structures.61-63

1.2.2 Ventricular Noncompaction Defects
Aberrant ventricular chamber maturation can lead to left ventricular noncompaction (LVNC), which is characterized by excessive trabeculae, deep recesses
within the ventricular cavity and a thin compact myocardium. This defect is called LVNC
because it affects mostly the LV but in rare cases, this defect can also occur as an isolated
incident in the RV. LVNC can occur as an isolated event or combined with other CHDs,
leading to heart failure, thromboembolic events, arrhythmias and/ or sudden cardiac
death.133-135 LVNC is the third most common cardiomyopathy after dilated
cardiomyopathy and hypertrophic cardiomyopathy.136 Numerous studies have shown that
ventricular noncompaction arises from impaired maturation or arrest of the developing
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ventricular myocardium. This defect has been linked to mutations in mitochondrial
proteins, along with cytoskeleton, Z-line and sarcomeric proteins. For example, in one
family with LVNC, a mutation in the cardiac troponin T gene was found. However,
recapitulation of this mutation in a mouse model did not cause LVNC. Overall, this type
of defect is still relatively not well understood and there seems to be a lack of a genotypephenotype link, suggesting genetic heterogeneity in patients.137,

138

Numerous mouse

models have been developed in the past 10 years to study the genetic and molecular
mechanisms of LVNC including the Noonan syndrome SHP2 gain-of-function mutation
mouse and mouse with myocardial deletion of M1B1, a gene involved in the Notch
pathway.139, 140 However, the defects in the ventricular myocardium are not homogenous
between the mouse models, likely reflecting the complexity underlying chamber
development and maturation.

1.2.3 Outflow Tract Defects
Proper development of the cardiac OFT requires complex temporal and spatial
coordination between different cardiac progenitor populations, as previously described
above. Due to the developmental intricacies of this part of the heart, the OFT is
particularly susceptible to developmental defects. Abnormalities in OFT development
account for 20 – 30% of the CHDs seen at birth in humans.141 Even after postnatal
surgical correction, patients can still face health risks throughout their lives.142 The OFT
defects discussed in this thesis include OFT alignment defects, which include DORV and
overriding aorta, transposition of the great arteries (TGA), persistent truncus arteriosus
(PTA), aortic and pulmonary artery stenosis and vascular rings.
•

Double Outlet Right Ventricle (DORV)
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During normal cardiac development, the heart tube undergoes rightward looping,
convergence of the inflow and outflow poles of the heart tube and wedging of the aorta
between the two atrioventricular valves.143 Correct alignment of the aorta and pulmonary
artery with the LV and RV, respectively, is dependent on proper lengthening of the
venous (inflow) and arterial (outflow) poles of the primary heart tube. Consequently, a
shortened heart tube alters the alignment of the arterial pole, causing DORV, where both
the pulmonary artery and aorta connect to the RV, or overriding aorta, where the aorta is
positioned above a VSD (Figure 1.2B).43 DORV account for 1-3% of CHDs and requires
surgical correction. The causes of DORV are complex and multifactorial including
chromosomal and non-chromosomal genetic abnormalities and teratogenic exposures in
utero.144 From animal studies, DORVs have been shown to arise from impaired neural
crest cell and SHF progenitor contribution to the primary heart tube, leading to a
shortened heart tube and subsequent defects in cardiac looping.80 In addition, defects in
the myocardialization process have been shown to also lead to DORV. Myocardialization
is a process where myocardial cells migrate and grow into the adjacent mesenchymal
tissue. At E12, myocardial cells of the OFT will invade the neighbouring cushion
mesenchyme, leading to a gradual replacement of the mesenchymal tissue with
myocardium to form the muscular outlet septum.145 Failure of myocardialization leads to
misalignment of the OFT and the aorta remains in contact with the RV.146
•

Transposition of the Great Arteries (TGA)

TGA occurs when the aorta is connected incorrectly to the RV and the pulmonary
artery is connected incorrectly to the LV (Figure 1.2C). TGA arises from abnormal
septation of the aorticopulmonary septum between the aorta and pulmonary artery.
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During normal development, the aorticopulmonary septum is formed in a spiral shape,
causing the OFT to rotate and the aorta and pulmonary artery to align with their
respective ventricles. TGA arises when the aorticopulmonary septum does not spiral and
forms a straight, linear septum instead.78, 147 TGA is estimated to occur in 3.5/10,000 live
births, making it one of the more common major CHDs requiring corrective surgery
shortly after birth.148 Post-surgery, later health risks into adulthood can include atrial
arrhythmias, tricuspid regurgitation, RV dysfunction and pulmonary hypertension.125 The
detailed pathogenesis of TGA is still relatively unknown. A study in chick demonstrated
that neural crest ablation may lead to TGA but the mechanisms are unclear.149 TGA is
strongly associated with heterotaxy in humans and some patients with TGA have
mutations in ZIC3, CFC1 and Nodal, which are genes associated with laterality.150,

151

Along with genetic factors, environmental factors such as maternal diabetes and
infections have also been linked to development of TGA.148
•

Persistent Truncus Arteriosus (PTA)

PTA, also known as common arterial trunk, occurs when the OFT fails to divide into
aorta and pulmonary artery during development, resulting in one common artery that
arises from the ventricles (Figure 1.2D). The process of OFT septation is dependent on
cardiac neural crest cells, which migrate into the distal OFT and condense to form the
aorticopulmonary septation complex, dividing the common artery into two equal sized
vessels.41, 68 Studies have shown that ablation of cardiac neural crests in chick embryos
result in PTA.152 In mouse studies, alterations to the cardiac neural crest cells also lead to
PTA.153 Sema3c, a secreted axonal guidance molecule, is critical for migration and
targeting of cardiac neural crest cells to the OFT. Loss of Sema3c leads to PTA and aortic
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arch defects.69, 154 Other genetic mutations in mice that have been associated with PTA
include the transcription factors Pax3, AP2α and Pitx2, and signaling proteins, BmprII
and Alk2.36 PTA occurs in approximately 1% of infants born with CHDs and up to 50%
of PTA cases are associated with chromosome 22q11.2 deletion syndrome.155, 122 PTA is
often considered the most severe type of OFT defect, as it is usually associated with a
poor prognosis and complete repair is not possible in some patient cases. However, in the
last 30 years, surgical procedures for PTA have improved with a 95% survival rate. Many
patients often require later interventions related to RV flow obstruction and repair of the
truncal valves.156, 157
•

Aortic & Pulmonary Artery Stenosis

Stenosis of the pulmonary artery occurs when there is abnormal constriction or
narrowing of the pulmonary artery vessel. This leads to development of higher pressure
in the RV in an effort to overcome the narrowing of the pulmonary artery.158 Pulmonary
artery stenosis makes up one of the four characteristics of TOF, which also include VSD,
RV hypertrophy and overriding aorta.159 In addition, pulmonary artery stenosis is often
associated with Williams syndrome, which arises from deletion of a portion of
chromosome 7 and presents as connective tissue abnormalities, endocrine abnormalities
and mental retardation. Treatments for pulmonary artery stenosis include balloon dilation,
stent placement or surgical repair.160 Similar to pulmonary artery stenosis, stenosis of the
aorta is a narrowing of the blood vessel. This condition is also called supravalvular aortic
stenosis because the narrowing occurs above the aortic valve. This defect can be caused
by mutations in the ELN gene, which is responsible for production of tropoelastin, the
precursor of elastin. However, over 50% of supravalvular aortic stenosis has no known
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genetic cause.161 Surgical intervention is the primary treatment for supravalvular aortic
stenosis.162
•

Vascular Ring

A vascular ring is a vascular encirclement of the esophagus and trachea due to a
failure of the aortic arch arteries to remodel during cardiac development. Vascular rings
are found in less than 1% of CHDs. Some cases of vascular rings are asymptomatic while
others can present with major symptoms such as compression or obstruction of the
esophagus or airway.163 Up to 50% of patients with vascular rings also have other CHDs
such as VSD, TOF or patent ductus arteriosus (PDA). Non-cardiovascular associations
include genetic syndromes such as DiGeorge syndrome, Down syndrome and cleft lippalate.164,

165

Several types of vascular rings exist with the two most common being

double aortic arch and right aortic arch with left ligamentum arteriosum, comprising 8595% of vascular ring cases.164, 166 During early embryonic development, the dorsal and
ventral aortic arch are connected by six bilateral embryonic arches. Each arch will
develop into vasculature or regress. The first, second, fifth arches and part of the fourth
arch will regress. The third arch will become the common carotid arteries and the sixth
arch will form the proximal pulmonary artery and ductus arteriosus. Vascular rings can
arise when development or regression of one or more of the arches does not occur
normally.167 During development, a subpopulation of cardiac neural crest cells will
migrate into pharyngeal arches three, four and six to remodel the arteries. Failure of
cardiac neural crest cells to populate and remodel this region can lead to vascular rings.168
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Figure 1.2. Schematic representation of outflow tract defects.
In the normally developed heart, the OFT is fully septated. The aorta (Ao) connects to the
LV and the pulmonary artery (PA) connects to the RV (A). In cases of DORV, both the
aorta and pulmonary artery connect to the RV (B). In TGA, the aorta and pulmonary have
switched connections to their respective ventricles, where the Ao now connects to the RV
and the pulmonary connects to the LV (C). When the OFT fails to septate, a PTA occurs
(D). For all defects shown in B-D, there is an obligatory VSD.

1.3 Rac1 GTPase
1.3.1 Rac1 Overview
Rac GTPases are small (20-30 kDa) monomeric, signaling GTP-binding proteins,
which are a subfamily of the Rho GTPase family. The Rho GTPase family is comprised
of 8 subfamilies encompassing a total of 20 intracellular signaling molecules. The Rac
family contains 4 members: Rac1, Rac2, Rac3 and RhoG.

169, 170

Rac proteins play an

important role in various cellular events, including actin cytoskeletal reorganization and
lamellipodia formation for migration, transformation, proliferation, cell survival, gene
expression, endocytosis and trafficking and superoxide production.171-175 Rac1, Rac2 and
Rac3 have similar genetic sequences with different expression patterns. Rac1 is
ubiquitously expressed, whereas Rac2 expression is restricted to cells of hematopoietic
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origin176, 177 and Rac3 is most abundant in the brain.178, 179 RhoG has the lowest sequence
similarity to Rac1 and is ubiquitously expressed.180 The most well studied and
characterized protein of the Rac family is Rac1.

1.3.2

Activation of Rac1
Rac1 act as a molecular switch, cycling between active (Rac1-GTP) and inactive

(Rac1-GDP) forms on the cell membrane. Under basal conditions, inactive Rac1 localizes
in the cytosol and is bound to a GDP dissociation inhibitor (GDI). Upon stimulation by
various factors such as cytokines, Rac1-GDP dissociates from GDI and attaches to the
membrane. Two major classes of proteins facilitate binding and hydrolysis of GTP to
GDP on Rho GTPases, which are guanine nucleotide exchange factors (GEFs) and the
GTPase activating proteins (GAPs), respectively.
GEFs become activated and will open the Rac1 nucleotide-binding site to allow
the exchange of GDP for GTP and subsequent activation of downstream effectors.181
Activation of GEFs through upstream activation signals can occur through several
different mechanisms, which include protein-protein or protein-lipid interactions, binding
of second messengers and posttranslational modifications.182 For example, a common
activator of Rac-GEFs is phosphoinositide 3-kinase (PI3K) which induces GEF
membrane translocation and/or conformational changes.183 Some Rac-GEFs known to be
activated through PI3K include P-Rex, SWAP-70, Tiam1, Pix, Sos and Vav.183, 184 Some
common second messengers can also activate GEFs, including cyclic adenosine
monophosphate (cAMP), Ca2+ and diacylglycerol (DAG).182 Over 70 GEFs have been
reported in humans and in most cases, each GEF can activate multiple Rho GTPases,
creating a network of complex crosstalk between GEFs and Rho GTPase proteins.185 For
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example, the GEF Tiam1 can activate Rac1, Rac2 and Rac3 while another GEF, Vav1,
can also activate Rac1 along with RhoA, RhoG and Cdc42.186 Similar to GEFs, over 80
GAPs regulate Rho GTPases and can act on multiple Rho GTPases. Although GTPase
proteins have their own intrinsic GTP hydrolysis activity, the reaction speed is slow and
interaction with a GAP can accelerate the GTP hydrolysis reaction by several orders of
magnitude (Figure 1.3).187 To account for the large numbers of GEFs and GAPs
compared to Rho GTPase proteins, it has been shown that some GEFs and GAPs have
spatial-temporal specific expression and may regulate a specific Rho GTPase signaling
pathway.188 181

Figure 1.3. Schematic representation of the Rac1 activation cycle.
Rac1 will cycle from an inactive GDI-bound state in the cytosol to an inactive GDPbound state on the cell membrane. GEFs enable the exchange for GDP for GTP to
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activate Rac1, which will then activate downstream effectors. GAPs facilitate the
exchange of GTP for GDP, thus inactivating Rac1.

1.3.3 Pleiotropic Effects of Rac1
Activated Rac1 interacts with a multitude of effectors to activate downstream
signaling cascades and influence numerous, diverse physiological responses. Some
effectors of activated Rac1 include p67phox, IQ motif containing GTPase activating
proteins (IQGAPs), p21 activating kinases (PAK), Wiskott-Aldrich syndrome protein
with a V-domain (WAVE), and partitioning-defect-6 (PAR-6).171,

189

Interaction of

activated Rac1 with p67phox leads to activation of NADPH oxidase and production of
superoxide.190 IQGAPs stabilize active Rac1 and acts as a scaffolding protein to regulate
cell adhesion, actin cytoskeleton and cell cycle progression signaling pathways.191 Cell
adhesion and cytoskeleton dynamics can also be partially regulated through PAKs, along
with transcription and cell survival.192 Binding of activated Rac1 to WAVE protein leads
to activation of the actin-related-protein-2/3 (Arp2/3) complex which promotes actin
polymerization from the sides of existing filaments, creating a branched-actin-filament
network and lamellipodia formation.170 Activated Rac1 can also interact with PAR-6,
which forms a complex with PAR-3 and the Ser/Thr kinase atypical protein kinase C
isoform PKC (aPKC). PAR-6, PAR-3 and aPKC form the PAR complex, which is
involved in various aspects of cell polarity.193 Rac1 can also promote gene expression
through several different pathways, including NF-κB and PAK.194,

195

Through PAK,

Rac1 can mediate c-Jun N-terminal kinase (JNK) regulated canonical Wnt-signaling,
leading to downstream TCF/β-catenin transcriptional signaling.196 As well, studies have
shown that Rac1 activation of NF-κB, JNK and p38 mitogen-activated protein kinase
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(MAPK) can induce expression of the transcription factor activator protein-1 (AP1),
leading to expression of genes that regulate cell cycle progression.174 Hence, Rac1 is a
critical component of a complex signaling network in normal physiology and abnormal
Rac1 signaling has been implicated in various pathophysiologies including cardiac
hypertrophy, heart failure and atherosclerosis (Figure 1.4).197

Figure 1.4. Downstream effectors of Rac1.
Activated Rac1 signals to numerous downstream effectors to regulate diverse cellular
functions.

1.3.4

Rac1 and Embryonic Development
Rac1-/- mice are embryonic lethal by E9.5 with defects in germ layer formation

due to reduced cell adhesion and motility and apoptosis of the mesoderm tissue.198 Due to
the early lethality of Rac1-/- mice, many tissue specific Rac1 conditional knockout mouse
models using the Cre/loxP system have been generated to study tissue specific roles of
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Rac1. To date, Rac1 has been shown to be involved in numerous cellular processes in the
development of many tissues and organs. Mice with an endothelial-specific Rac1
excision are embryonic lethal by E9.5 with development defects of the major vessels and
a complete absence of small branched vessels. Endothelial cell-specific deletion of Rac1
blocks

cell

migration,

adhesion,

lamellipodia

formation,

permeability

and

tubulogenesis.199 In addition, mice with a forebrain-specific loss of Rac1 exhibit
decreased proliferation and migration of cortical neurons during development and
increased apoptosis of progenitors.200 During embryogenesis, specification of the
anterior-posterior body axis depends on migration of an extra-embryonic organizer
known as the anterior visceral endoderm (AVE).201 Rac1 is critical for specification of
the anterior-posterior axis by acting cell-autonomously within the migrating AVE cells to
extend projections and change cell shape. Rac1-/- mice fail to specify an anterior-posterior
axis since AVE cells do not migrate.202 In the mouse epiblast, deletion of Rac1 results in
embryonic lethality by E8.5. These mice have decreased migration of the mesoderm
tissue and large scale cell death leading to defects in embryonic morphogenesis including
failure of the lateral heart anlage to fuse, defects in closure of the neural tube and
defective paraxial mesoderm formation.203 Regarding cardiac development, when Rac1 is
specifically deleted in neural crest cells, OFT cushions are abnormally positioned, fused
and smaller. In these neural crest cell Rac1 mutants, the pharyngeal arches also failed to
remodel and the OFT remains unseptated, resulting in a common arterial trunk. Postmigratory Rac1-deficent neural crest cells also have an increased level of apoptosis and
decreased proliferation, along with defective cell organization.204 To date, the role of
Rac1 in other cardiac progenitor cells or cardiac tissues during development is unclear.
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One study by Wei et al., used a transgenic mouse line overexpressing RhoGDIα under
control of the cardiac-specific α-myosin heavy chain (αMHC) promoter. RhoGDIα is an
endogenous inhibitor of many Rho protein members including RhoA, RhoB, Rac1, Rac2
and Cdc42. RhoGDIα transgenic mice were found to have defects in cardiac looping and
ventricular maturation along with reduced cardiomyocyte proliferation. This study
established Rho proteins as critical regulators of cardiac development; however, the roles
and involvement of each specific Rho protein remained unclear.205 Therefore, the overall
three aims of this project were to determine the specific roles of Rac1 during embryonic
heart development.

1.4 Cell Polarity
Cell polarity is the asymmetrical organization of cell membrane proteins,
intracellular organelles and the actin cytoskeleton to influence cell shape and structure
and to regulate specialized cellular functions.206 Almost every eukaryotic cell possesses
polarity, which is coordinated spatially and temporally and regulated by numerous
signaling cascades and cytoskeleton dynamics. Many biological processes including
proliferation, apoptosis, cell shape and morphology, migration and differentiation are
coordinated and linked to polarization of a cell.

In addition to polarity within an

individual cell, polarity between neighbouring cells must also be coordinated in order to
form functional tissues and organs.207 Through cell polarization, diverse cell types with
specific functions are formed within an organism. A prime example is neurons, which
have a dendritic end for synaptic inputs and an axonal end for signaling outputs. Many
neurons will connect with each other to form a complex network to propagate signals
throughout the body.

208

Cell polarity is established through conserved polarity proteins
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complexes, which include partitioning defect (PAR), Crumbs and Scribble. These
polarity protein complexes will respond to extrinsic and intrinsic cues such as growth
factor gradients and cytoskeleton dynamics, respectively, to establish cell polarity.
Interestingly, recent studies have shown a critical requirement for crosstalk between
polarity protein complexes and effectors of small Rho GTPases in regulation of polarity
in several cell types including neurons, epithelial cells and T cells.193 For example, tight
junction formation in keratinocytes is dependent on the activation of PAR-3, a
component of the PAR complex, by the Rac1-GEF, Tiam1.209 Numerous studies have
shown a direct link between aberrant cell polarization and pathophysiologies such as
developmental defects in neural tube closure and cancer.210-212

1.4.1 Types of Cell Polarity
Different types of cell polarity exist including front-rear polarity seen in polarized
migrating cells, apico-basal polarity in epithelial cells and planar cell polarity (PCP). A
cell can take on different polarity characteristics depending on developmental cues and
spatial and temporal factors. For example, in formation of epithelial cells during
development, migratory mesenchymal cells undergo a mesenchymal-to-epithelial
transition (MET), transitioning from a migratory cell with front-rear polarity to one of an
epithelial cell with apical-basal polarity. This polarity transition involves dynamic
changes to the actin cytoskeleton, protein localization and trafficking pathways.213
•

Front-Rear Polarity

Front-rear polarity exists when the front leading edge and the back end of a migrating
cell show morphological and functional asymmetry.206,

214

The Rho GTPases, Cdc42,
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RhoA and Rac1, are distinctly localized to the front (Rac1 and Cdc42) or back (RhoA)
while centrosomes, microtubules and Golgi are oriented towards the front of a migrating
cell. Polarity protein complexes also tend to be localized to the leading edge.215,

216

Cellular functions such as protein trafficking are also polarized in a migratory cell.
Through the endocytic pathway, integrins are redistributed from the back to the front of a
migrating cell. The exocyst complex, which tethers transport vesicles to sites of fusion, is
localized to the front of a migratory cell and is responsible for exocytosis and endocytosis
of integrins in the front.217, 218 This distinct organization between the front leading edge
and back of cells is intrinsic to migratory ability (Figure 1.5A).214
•

Apical-Basal Polarity

Apical-basal polarity is cellular asymmetry along the apical-basal cell axis and is a
major feature of epithelial cells. Mammals have over 150 different types of epithelial
cells that play critical roles in embryo morphogenesis, along with formation and function
of numerous organs.219 The apical membrane domains of epithelial cells face the lumen
or external environment while the basolateral membrane domain maintains contact with
neighbouring cells or the underlying ECM. The correct localization of polarity proteins
and cell-cell junctions is crucial for establishment of polarity and for designating the
apical and basolateral domains. The PAR and Crumbs polarity protein complex define
the apical domain while the Scribble polarity protein complex is found in the basolateral
domain.220, 221 Cell-cell junctions, which include adherens junctions, tight junctions, gap
junctions and desmosomes, are located at distinct regions along the apical-basal axis.
Tight junctions prevent the diffusion of proteins between the apical and basolateral
surfaces, thus maintaining apical-basal polarity. Adherens junctions, found basal to tight
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junctions, form a band that encircles the cell and provide adhesion between neighbouring
epithelial cells. The formation of both adherens junctions and tight junctions are highly
interconnected where formation of early adherens junctions are a prerequisite for tight
junction formation.222, 223 Along with structural polarity, functional polarity involving ion
channels also exist to create a sodium gradient to move other ions and solutes across the
epithelium. A polarized epithelial layer permits functional compartmentalization,
allowing exchange of nutrients and waste between the internal and external environments
(Figure 1.5B). A wide range of signaling pathways have been implicated in regulation of
apical-basal polarity including TGFβ, integrin, Hippo and Wnt.224,

225

Establishment of

apical-basal polarity is also linked to numerous cellular processes including proliferation,
cell morphology and maintenance of overall tissue architecture.226 Loss of apical-basal
polarity in epithelial cells is the source of approximately 90% of all human cancers.227
•

Planar Cell Polarity

PCP is the alignment of cells across a tissue plane. PCP is orthogonal to the axis of
apical-basal polarity and occurs between adjacent cells, allowing for coordinated
alignment of numerous cells in a tissue. The PCP signaling pathway is well understood in
Drosophila and many of the signaling components are well conserved in vertebrates and
mammals. Various processes such as gastrulation, orientation of stereocilia within the
inner ear, neural tube closure and oriented cell division are dependent on PCP genes.228231

PCP can be divided into two distinct molecular systems: a global group of proteins

(Fat, Dachsous and Four-jointed), which regulate polarity in the direction of the body
axis and a core group of proteins (Frizzled, Dishevelled, Prickle, Van Gogh, Diego and
Flamingo), which regulate polarization signals within individual cells. A common feature
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of both the global and core system is the asymmetrical distribution of their components
(Figure 1.5C).232 The PCP pathway will signal to downstream effectors that include
RhoA and Rac1, leading to changes in the actin cytoskeleton and generation of
morphological asymmetry (Figure 1.6). In vertebrates, non-canonical Wnts, which
include Wnt5a and Wnt11, will bind to the Frizzled receptor. This leads to recruitment of
Dishevelled to the plasma membrane and activation of diverse pathways. Specifically,
Dishevelled binds Daam1 (DVL-associated activator of morphogenesis 1) and activates
RhoA to regulate the actin cytoskeleton in cell polarity and migration. In a parallel PCP
pathway, Dishevelled binds to Rac1 to signal through JNK, leading to gene transcription
and changes in the actin cytoskeleton and cell polarity.233,

234

Disruptions to PCP

signaling can cause severe developmental defects including skeletal defects, left/right
patterning defects and ciliopathies.235-237
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Figure 1.5. Different types of cell polarity.
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(A) Rho GTPases, polarity protein complexes, along with other cellular components have
a polarized distribution, creating front-rear polarity in a migratory cell. (B) Epithelial
cells have apical-basal polarity. The apical and basal domains have distinct localization
of polarity protein complexes, cell-cell junctions and ion channels to regulate epithelial
function. (C) PCP is the alignment of adjacent cells within the plane of a cell sheet. Core
PCP proteins have an asymmetrical distribution within a cell, which is critical for
establishment of PCP in a tissue. C, centrosome; TJ, tight junction; AJ, adherens junction
Figure adapted with modifications from Nelson, WJ. Cold Spring Harb Perspect Biol.
2009;1:a000513 and Devenport, D. J Cell Biol. 2014;207(2):171-179.

Figure 1.6. The outcome of PCP: Actin cytoskeleton organization, cell shape,
migration and alignment.
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Core PCP proteins in the posterior end of a cell (Frizzled, Diego and Dishevelled) signal
to downstream effectors, which include Rac1 and RhoA, leading to actin reorganization
and overall polarization of cells.

1.4.2 Rac1 & Cell Polarity
Rac1 signaling has been shown to be a critical regulator of several cell
polarization events including polarized migration, apical-basal polarity and PCP. The
crucial role of Rac1 in establishment of cell polarity is not surprising, given its
established function in actin polymerization and regulation of cytoskeleton dynamics.170
In front-rear polarity, proper polarization and directed cell migration requires Rho
GTPase activity and crosstalk with polarity proteins. Cell migration is the net outcome of
Cdc42 and Rac1-directed formation of cell protrusions at the front leading edge and
RhoA-directed retraction of adhesion complexes at the rear of a migrating cell.238 In
migratory cells, activated Rac1 will localize at the front leading edge to form adhesions
and activate WAVE and Arp2/3 protein complexes, leading to subsequent actin
polymerization and lamellipodia formation. RhoA is mutually antagonistic to the activity
of Rac1 and is most active at the rear and sides of a cell, responsible for actomyosin
contraction necessary for cell detachment during migration.215, 216 In addition, the polarity
protein complexes, PAR, Crumbs and Scribble, are located at the leading edge of a
migrating cell.215, 216 Scribble can localize Rac1 to the front edge, promoting subsequent
polarization of the Golgi apparatus and cell migration.239 Decreased Scribble expression
can lead to reduced Rac1 activation, indicating a direct or indirection regulation of Rac1
by Scribble.211 Defects in front-rear polarity induced through inhibition of the small
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GTPases, Rac1 or RhoA, or disruptions in cytoskeleton organization have been shown to
result in global loss of migratory ability in neutrophils.214
Spatiotemporal regulation of Rac1 signaling has been demonstrated to be
important for correct apical-basal polarization. Rac1 activity is critical for directing
where the apical domain will form. Rac1 promotes assembly of the laminin basement
membrane by regulating dystroglycan or β1-integrins, thus generating the correct tissue
architecture to orient apical-basal polarity. Blocking Rac1 activity and laminin assembly
leads to inversion of apical-basal polarity.240,

241

Activity of Rac1 is also differentially

regulated along the apical-basal axis, with activity being higher at adherens junctions and
lower at tight junctions, which is crucial for cell-cell junction formation.242, 243 Clustering
of E-cadherin at sites of cell-cell contact formation leads to activation of Rac1. Local
Rac1 activity will drive the formation of actin-based protrusions, leading to formation of
lamellipodia and promotion of E-cadherin-mediated adherens junction formation with
neighbouring cells.244, 245 In addition, activation of the PAR polarity complex by Rac1Tiam is required for tight junction formation.246 Aberrant Rac1 activity can disrupt
adherens junction formation and perturb tight junction function, causing overall loss of
apical-basal polarity. Thus, proper formation of cell junctions and establishment of
apical-basal polarity requires tight regulation of Rac1 activity, coinciding with correct Ecadherin localization and regulators of the actin cytoskeleton.247, 248
Overall tissue organization and polarity is also regulated in part by Rac1
signaling. However, the downstream effectors of PCP can vary between organisms and
tissues. In Drosophila eye development, Frizzled and Dishevelled will signal to Rac1,
leading to nuclear activation through JNK.249 In vertebrates, non-canoical Wnts (Wnt5a
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and Wnt11) will bind to the transmembrane receptor, Frizzled, leading to recruitment of
the scaffolding protein, Dishevelled and downstream activation of Rac1.250 Rac1 has
been shown to be a crucial effector of the PCP pathway during convergent-extension
movements in gastrulation.198,

251

In addition, the core transmembrane PCP protein,

Vangl2, recruits Rac1 to regulate adherens junctions, which is critical to neural tube
closure.252 Rac1 signaling through PAK and downstream regulation of actin dynamics
play a critical role in morphogenesis of the auditory sensory epithelium and stereociliary
bundle of the inner ear. Conditional loss of Rac1 activity in the developing inner ear lead
to overall misorientation and misalignment of hair bundles, similar to what is observed in
PCP mutants.253

1.4.3 Cell Polarity & Heart Development
Development of the heart is a dynamic process involving changes in cell shape
and morphology, cell orientation and migration and tissue remodeling. Cell polarity is
implicated early on in cardiac development during migration of cardiac progenitors to the
embryonic midline and establishment of the early heart tube.254, 255 In early development,
cardiomyocytes are a spherical, cuboidal-like shape and junctional proteins are
distributed uniformly throughout the cell membrane.256 By E13.5, cardiomyocytes start to
elongate and cell junctional proteins will begin to rearrange within the membrane.
Following two weeks after birth, cardiomyocytes will continue the polarization process to
acquire the typical rod-shape of adult cardiomyocytes, undergoing progressive alignment
with neighbouring cardiomyocytes. Junctional proteins, which include adherens junctions
and desmosomes that anchor actin filaments and intermediate filaments, respectively, will
become restricted to the intercalated discs by P10. Gap junction proteins have a distinct
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pattern from junctional proteins and are only restricted to the intercalated discs by one
month after birth.256, 257 Beyond the cellular level, a recent study showed that within the
developing embryonic myocardium, cardiac cells are locally coordinated and
preferentially align and divide in a plane parallel to the outer surface of the heart.258 In
addition, different areas of the ventricle have various orientations of cardiomyocyte
growth, following a circumferential, radial or perpendicular orientation relative to the
ventricular wall.259,

260

Cardiomyocytes in the subendocardial and subepicardial layers

form helical sheets while cardiomyocytes in the middle layer form a circular sheet.261
Although the cardiomyocyte polarization process has been well documented, the signals
regulating and coordinating this process of polarization during embryonic and postnatal
development are still relatively unclear.
Recent studies have demonstrated a critical role for PCP in embryonic heart
development. Specifically, mutations in Vangl2 or Scribble, components of the PCP
pathway, led to abnormal organization and noncompaction of the ventricular
myocardium. The developing cardiomyocytes failed to elongate and polarize, instead,
retaining a spherical shape in PCP mutants.146, 262 As well, common to many PCP mutants
was a defect in septation and alignment of the great arteries with their respective
ventricles, strongly supporting a critical role for PCP signaling in OFT development.262-265
However, these mutation studies were unable to determine the major cell types in which
PCP signaling was required for cardiac development. Subsequent studies involving
tissue-specific deletions of the PCP genes, Dvl1/2, Vangl2 and Wnt5a revealed a critical
requirement for PCP signaling in SHF cells. Disruption of PCP signaling in the SHF
resulted in defects in SHF progenitor cell deployment, shortened OFT length, defects in
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cardiac looping and abnormal SHF progenitor cell morphology and behaviour.266-268
Interestingly, the importance of PCP signaling during cardiac development seems to be
species and cell type dependent. Although a critical requirement for PCP signaling in
neural crest cells was described in fish and frogs, the role of PCP signaling in mouse
neural crest cells is still relatively unclear.269, 270 Vangl2 (looptail; Lp/Lp) mutant mice
lack PCP signaling and fail to complete neural tube closure. However, neural crest cell
specification and migration occurs normally in the Lp/Lp mice.269 In addition, although
Lp/Lp mice have CHDs, migration of cadiac neural crest cells into the developing OFT
was shown to be normal.263 In contrast, Dvl2 mouse mutants were reported to have OFT
defects and displayed abnormalities in cardiac neural crest cell migration into the
developing heart.271 However, a subsequent study using the cardiac neural crest specific
Wnt1-Cre mouse to delete Dvl1 and Dvl2 found no CHDs or defects in cardiac neural
crest cells.266 Potential explanations for these conflicting findings regarding PCP
signaling in mouse neural crest cells include functional redundancy between PCP genes
and/or secondary defects to other cell types, such as the SHF cells. Further studies with
cardiac neural crest specific deletions of PCP genes should be performed to determine the
exact role of the PCP pathway in mouse neural crest cells.
In addition to PCP, SHF progenitors also exhibit characteristics of apical-basal
polarity. Before discovery of the SHF, a pioneering study in 1973 was one of the first to
describe a population of cells adjacent to the distal border of the heart that formed a
cuboidal epithelium of mesenchymal cells.272 In later studies in chicks, SHF progenitors
were described to possess a pseudo-stratified columnar layer of epithelium.273 This
organized, epithelial characteristics of SHF progenitors with apical-basolateral domains,
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tight junctions and adherens junctions, apical monocilia and dynamic basal filopodia has
also been confirmed in subsequent mouse studies.268, 274 The transcription factor, TBX1,
was shown to be a critical regulator of SHF apical-basal polarity and cell morphology.
TBX1 regulates proliferation and differentiation of the SHF and is the major gene affected
in DiGeorge syndrome (DGS). DGS manifests from heterozygous deletion of a region of
chromosome 22q11.2 causing OFT defects along with other developmental defects.275, 276
Loss of TBX1 resulted in cell shape changes in the SHF, decreased basolateral membrane
domain and impaired filopodia activity, demonstrating a critical link between the
epithelial properties of SHF progenitors and OFT development.274 However, the role of
Rac1 in regulation of cell polarity in SHF progenitors and OFT development is not clear.

1.5 Rationale and Hypothesis
CHDs are the most common type of congenital defect in humans, representing
28% of all major congenital anomalies worldwide.277 Medical advancements have
dramatically increased the survival rate of patients born with these types of defects.
However, CHD adult patients often need long-term expert medical care and treatment,
making this disease a major global health burden.278 The origins of CHDs are often
complex and multifactorial, with both environmental and genetic contributions. Despite
much progress in our understanding of the molecular and cellular mechanisms of heart
development through the use of various animal models, our understanding of the etiology
of CHDs is still incomplete.127, 128
In recent years, research has demonstrated a critical role for cell polarity in
embryonic development of the heart. Mature cardiomyocytes are oriented and organized
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in a polarized manner within the heart but the signaling pathways regulating this polarity
are not well known.256,

259

Using mouse models, several studies showed that SHF

progenitors require PCP signaling for proper development of cardiac structures such as
the OFT and ventricular myocardium. In addition, SHF progenitors form an apicobasallypolarized epithelium in the dorsal pericardial wall before migration and differentiation in
the heart tube. Disruption of this SHF polarity at an early stage impacts downstream
development of SHF-derived cardiac structures.257,

274

Rac1 is a pleiotropic effector of

numerous cellular processes including actin polymerization and regulation of
cytoskeleton dynamics, which are processes involved in regulation of cell polarity.170 The
role of Rac1 has been demonstrated in various aspects of cell polarity including front-rear
polarity during neutrophil cell migration, orientation of epithelial apical-basal polarity
and in PCP-regulated convergent-extension movements during gastrulation.214,

240, 251

However, the role of Rac1 and regulation of cardiomyocyte polarity during heart
development is unknown. Thus, the main goal of this thesis project is to understand the
role of Rac1 in cell polarity during heart development. The overall hypothesis of this
thesis is that Rac1 is required for cardiomyocyte polarity and embryonic heart
development.

1.5.1 Aim 1: Rac1 and Cardiomyocyte Polarity
The first aim of this thesis was to study the role of Rac1 in cardiomyocyte polarity
and embryonic heart development using a mouse line with an anterior SHF-specific Rac1
deficiency, Rac1SHF. Early cardiomyocytes have a cuboidal shape and will gradually take
on a polarized, elongated morphology by two weeks postnatally in the mouse. Junctional
proteins go from being uniformly distributed in embryonic cardiomyocytes to restricted
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at the ends of the rod-shaped adult cardiomyocytes.256,

257

What regulates this

cardiomyocyte polarization process is still not fully understood. Rac1 is involved in
reorganization of the actin cytoskeleton, which drives cell shape changes and
migration.251 Studies have shown that PCP mutants have cardiomyocytes that fail to
elongate and polarize during development.146, 262 However, whether Rac1 is a downstream
effector of the polarity pathways that exist in developing cardiomyocytes is unclear.
Thus, the hypothesis of the first aim of this thesis is that Rac1 is a critical regulator
of cardiomyocyte polarity and development of RV myocardium and cardiac septum.
The objectives of the first study were:
1. Generate a mouse line with an anterior SHF-specific Rac1 deficiency, Rac1SHF.
2. Analyze Rac1SHF hearts for CHDs and defects in cardiomyocyte polarity.
3. Determine the role of Rac1 in SHF progenitors during embryonic heart
development.

1.5.2 Aim 2: Rac1 and Outflow Tract Development
Development of the OFT seems to be especially dependent on cell polarity
signaling mechanisms. Disturbances in PCP signaling in the SHF result in a spectrum of
OFT defects, supporting a critical role for polarity in development of the OFT.266, 267 In
addition to PCP signaling, SHF progenitors in the dorsal pericardial wall are organized
into a polarized epithelium. Disruption of SHF progenitor apical-basal polarity impacts
proper development of the OFT.274 This suggests that Rac1 signaling in the SHF may
have a crucial role in OFT development, given its known role in actin organization
downstream of cell polarity signaling pathways.251 Therefore, the hypothesis of the
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second aim of this thesis is that Rac1 regulates SHF progenitor polarity and OFT
development.
The objectives of the second study were:
1. Analyze Rac1SHF embryos for defects in SHF progenitor cell polarity.
2. Analyze Rac1SHF hearts for OFT defects.
3. To understand the mechanism by which Rac1 signaling in the SHF regulates
OFT development.

1.5.3 Aim 3: Rac1 and Ventricular Myocardium Development
The developing ventricles have a high rate of proliferation and undergo a process
of remodeling and compaction to form the trabeculae and compact myocardium. The
mature myocardium is high organized with aligned, polarized cardiomyocytes.72 Multiple
signaling pathways have been shown to play a role in ventricular myocardium
development including Notch, BMP, FGF, retinoic acid and PCP signaling.70,

279

However, the complete signaling mechanisms underlying ventricular myocardium
development are still not completely understood. The known role of Rac1 in regulation of
proliferation and cell organization suggests a role for Rac1 signaling in development of
the ventricular myocardium.171 The Nkx2.5-Cre transgenic mouse was used for the third
study to elucidate the role of Rac1 in ventricular myocardium development. The Cre
recombinase in the Nkx2.5-Cre transgenic mouse is activated by E8.5.114 Therefore, the
hypothesis of the third aim of this thesis is that Rac1 regulates proliferation and
orientation of cardiomyocytes and development of the ventricular myocardium.
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The objectives of the third study were:
1. To generate a ventricular myocardium specific Rac1 conditional knockout mouse
(Rac1Nkx2.5).
2. To analyze Rac1Nkx2.5 hearts for CHDs and defects in proliferation and orientation
of cardiomyocytes.
3. To understand the mechanisms by which Rac1 signaling regulates proliferation
and organization of cardiomyocytes in the ventricular myocardium.
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Chapter 2

2.1 Chapter Summary
Defects in cardiac septation are the most common form of congenital heart disease but
the mechanisms underlying these defects are still poorly understood. The small GTPase
Rac1 is implicated in planar cell polarity of epithelial cells in Drosophila. However, its
role in mammalian cardiomyocyte polarity is not clear. Here, we tested the hypothesis
that Rac1 signaling in the second heart field (SHF) regulates cardiomyocyte polarity,
chamber septation and right ventricle (RV) development during embryonic heart
development. Mice with SHF-specific deficiency of Rac1 (Rac1SHF) exhibited ventricular
and atrial septal defects, a thinner RV myocardium and a bifid cardiac apex. Fatemapping analysis showed that SHF contribution to the interventricular septum and RV
was deficient in Rac1SHF hearts. Notably, cardiomyocytes had a spherical shape with
disrupted F-actin filaments in Rac1SHF compared to elongated and well aligned
cardiomyocytes in littermate controls. Expression of Scrib, a core protein in planar cell
polarity, was lost in Rac1SHF hearts with decreased expression of WAVE and Arp2/3,
leading to decreased migratory ability. Additionally, Rac1 deficient neonatal
cardiomyocytes displayed defects in cell projections, lamellipodia formation and cell
elongation. Furthermore, apoptosis was increased and the expression of Gata4, Tbx5,
Nkx2.5 and Hand2 transcription factors was decreased in the Rac1SHF RV myocardium.
Deficiency of Rac1 in the SHF impairs elongation and cytoskeleton organization of
cardiomyocytes, and results in congenital septal defects, thin RV myocardium and a bifid
cardiac apex. Our study suggests that Rac1 signaling is critical to cardiomyocyte polarity
and embryonic heart development.
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2.2 Introduction
The adult cardiomyocytes are highly polarized with a rod shape and the majority of
their cell junction proteins localized to the intercalated discs, joining the cells end to end to
facilitate electrical conduction and contraction of the heart.1 However, during embryonic
development, cardiomyocytes are initially formed in spherical shapes. They begin to
elongate at E13.5 and gradually assume a rod shape during fetal and postnatal development.
The spatial differences or asymmetries in the shape, orientation and structure of cells define
cell polarity, which is controlled by planar cell polarity (PCP) signalling, also known as the
non-canonical Wnt pathway.2 Initially identified in Drosophila, the PCP pathway is well
conserved in mammalian species.1,

3

The ligands of this pathway include Wnt5a and

Wnt11. The transmembrane receptors involved are Frizzled and Vangl2/Scrib. Through
recruitment of Dishevelled, the PCP signals are transduced to the small GTPases RhoA
and Rac, which in turn regulate actin polymerization and cell polarity.1, 2 The important
role of PCP signaling in regulating cardiomyocyte polarity and embryonic heart
development has recently emerged. Genetic knockout or mutation of PCP components
such as Wnt11, Vangl2, Scrib, and Dishevelled2 in mice all show congenital heart
defects.4-6 Additionally, Wnt11-/- and Vangl2 mutant mice show thin myocardium and
defects in cardiomyocyte elongation, organization and migration.4, 5 However, the role of
Rac in cardiomyocyte polarity and embryonic heart development is unknown.
Rac GTPases are small (20-30 kDa) monomeric, signaling GTP-binding proteins,
which are a subfamily of the Rho family of GTPases with four members: Rac1, Rac2,
Rac3 and RhoG.7 Rac1 is a key molecule in the PCP pathway to promote cell polarity of
the eyes and wings in Drosophila.8, 9 Rac1 is also an important regulator of cell migration
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and survival. Whole body Rac1-/- mice die before E9.5, with defects in germ layer
formation due to reduced cell adhesion and motility and increased apoptosis within the
mesoderm.10 Furthermore, Rac1-/- embryos fail to specify an anterior-posterior axis since
cells in the anterior visceral endoderm do not migrate,11 suggesting an important role of
Rac1 in cell polarity during embryogenesis.
The heart develops from three distinct populations of cells: the first heart field
(FHF), second heart field (SHF) and cardiac neural crest. Initially, the primary heart tube
is formed mainly from the FHF progenitors. SHF cells are then added to the heart tube to
form the right ventricle and the outflow tract with contributions from the cardiac neural
crest cells.12, 13 Additionally, SHF progenitors are critical to the formation of the cardiac
septum. Abnormalities in SHF development result in congenital heart defects (CHDs) in
mice including septal defects, which are some of the most common types of CHDs in
humans.14,

15

To specifically study the role of Rac1 in cardiomyocyte polarity, right

ventricle and cardiac septal development, we have generated a novel mouse model with a
SHF (or anterior heart field, AHF) specific deficiency of Rac1 (Rac1SHF) using the
Mef2c-Cre mouse, which directs Cre activity in the SHF.16 Our results show that Rac1
signaling in the SHF is critical to cardiomyocyte polarity, cardiac septation and RV
development.

2.3 Methods
2.3.1 Mice
Rac1f/f C57BL/6 mice (Stock #5550),17 and C57BL/6 mT/mG mice (Stock
#7676)18 were obtained from Jackson Laboratory (Bar Harbor, Maine). The mT/mG
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mouse is a global double-fluorescent Cre reporter mouse, which expresses membranetargeted Tomato (mT) before Cre-excision and membrane-targeted GFP (mG) after
excision of mT.18 The Mef2c-Cre embryos16 were obtained from Mutant Mouse Regional
Resource Centers (MMRRC, Chapel Hill, North Carolina) and rederived. A breeding
program was carried out to generate Mef2c-Cre;Rac1f/f (Rac1SHF), Mef2c-Cre;mT/mG and
Rac1SHF;mT/mG transgenic mice. Genotyping was performed by PCR using genomic
DNA from tail biopsies. Primer sequences can be found in Table 2.1. All mouse
experiments and procedures were carried out in accordance with the guidelines of the
Canadian Council of Animal Care and approved by the Animal Use Subcommittee at the
University of Western Ontario, Canada.
Table 2.1. The genotyping PCR primer sequences.
Gene

Forward

Reverse

Mef2c-Cre

tgccacgaccaagtgacagc

ccaggttacggatatagttcatg

Rac1f/f

tccaatctgtgctgcccatc

gatgcttctaggggtgagcc

mTmG

ctctgctgcctcctggcttct

cgaggcggatcacaagcaata
Mutant reverse:
tcaatgggcgggggtcgtt

2.3.2 Histological Analysis
Neonatal and embryonic samples were fixed overnight in 4% paraformaldehyde at
4°C, dehydrated and paraffin embedded. Embryos were serially sectioned at 5 µm from
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the top of the aortic arch to the apex with a Leica RM2255 microtome. Sections were
mounted onto positively charged albumin/glycerin coated microslides in a set of five,
with 25 µm intervals between each section. Slides were stained with hematoxylin and
eosin (H/E) for histological analysis. Images were captured using a light microscope
(Observer D1, Zeiss, Germany).

2.3.3 Immunohistochemistry
Immunohistochemical staining was performed on heart sections (5 µm). Antigen
retrieval was carried out in sodium citrate buffer (pH 6.0) at 92 °C using a BP-111
laboratory microwave (Microwave Research & Applications, Carol Stream, Illinois).
Immunostaining was performed with primary antibodies for Rac1 (Santa Cruz),
phosphohistone-H3 (phospho S10) (Abcam), cleaved caspase-3 (Cell Signaling), active
(non-phosphorylated) β-catenin (Cell Signaling) and GFP (Abcam). All slides were
imaged with Zeiss Observer D1 microscope using AxioVision Rel 4.7 software. For
phalloidin and wheat germ agglutinin (WGA) staining, P0 heart samples were fixed in
4% paraformaldehyde, cryoprotected in 30% sucrose, embedded in FSC22 frozen section
media (Leica) and sectioned with a Leica cryostat at 10 µm thick onto glass slides. Slides
were incubated with Alexa Fluor 488 phalloidin (Life Technologies), Alexa Fluor 647
WGA (Invitrogen) and Hoechst 33342 (Invitrogen). Confocal images were obtained with
a Zeiss LSM 510 Duo microscope using ZEN 2012 software (Zeiss, Germany).

2.3.4 Western Blot Analysis
Rac1 protein expression from P0 RV was measured by western blot analysis.
Briefly, 40 µg of protein from isolated RV tissue was separated by 12% SDS-Page gel
and transferred to nitrocellulose membranes. Blots were probed with antibodies against
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Rac1 (1:500, Santa Cruz) and GAPDH (1:3000, Santa Cruz). Blots were then washed and
probed with horseradish peroxidase conjugated secondary antibodies (1:2500, Bio-Rad)
and detected using an ECL detection method. Signal quantification was performed by
densitometry.

2.3.5 RV Explant Culture
Embryos were harvested at E12.5 and embryonic hearts were dissected to separate
RV tissue from the whole heart. RV tissues were cultured on 1% collagen-coated tissue
culture plastic multiwell plates, as previously described 19 with the following adaptations.
Explants were incubated for six days at 37°C with 5% CO2 in Dulbecco’s modified eagle
medium (DMEM) containing 10% FBS and 1% penicillin/streptomycin. Media was
refreshed every two days.

2.3.6 Quantitative Real-Time RT-PCR
Total RNA was isolated from E13.5 RV using the RNeasy Mini Kit (QIAGEN).
Reverse transcription reaction was performed using M-MLV Reverse Transcriptase
(Invitrogen) and EvaGreen qPCR Mastermix (Applied Biological Materials Inc.) was
used for real time thermal cycling. Samples were amplified for 35 cycles using the
Eppendorf Mastercycler Realplex Real-Time PCR machine. 28S rRNA was used as an
internal control. Primer sequences can be found in Table 2.2. The mRNA levels in
relation to 28S rRNA were determined using a comparative CT method.20
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Table 2.2. The real-time RT-PCR primer sequences.
Gene

Forward

Reverse

Arp2

ggcttttctctccctcacct

gcttctgctcctgctcaata

Arp3

cggcgtcctctctacaagaa

cagcattgaccctccaaacc

Abi1

ttgactccacagatccctctcac

ttcatagtccacaggaggaggtg

WAVE2

gcaaggaagagtgggagaagatg

cagagaatgaaggggaaggtgag

Nkx2.5

tcaatgcctatggctacaacg

gacgccaaagttcacgaagttgct

Gata4

cactatgggcacagcagctc

gcctgcgatgtctgagtgac

Tbx5

acacaggatgtctcggatgc

gttaggtgggggcagaaggt

Rac1

aacctgcctgctcatcagtt

ttgtccagctgtgtcccata

Tbx20

cacctatggggaagaggatgttc

gtcgctatggatgctgtactggt

Hand2

gctacatcgcctacctcatggat

tcttgtcgttgctgctcactgt

28S

ttgaaaatccgggggagag

acattgttccaacatgccag

2.3.7 Scratch Assay
Wild-type neonatal cardiomyocytes were prepared and cultured as previously
described.21 Cardiomyocytes were infected with adenoviruses expressing a dominantnegative form of Rac1 (Ad-Rac1N17, Vector Biolabs, Philadelphia, PA, USA) or β-
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galactosidase (Ad-β-gal, Vector Biolabs) as a control at a multiplicity of infection of 10
plaque forming units/cell. The scratch was performed 6 hours after adenoviral infection.
Cells were fixed and immunostained with primary antibodies for Rac1 (Santa Cruz) and
α-actinin (Sigma) 24 hours after scratch.

2.3.8 Statistical Analysis
Data are means ± SEM. Unpaired Student’s t test was used when data passed a
normality test. Nonparametric Mann-Whitney test was employed when samples size was
3-4 per group. Differences were considered significant at P≤0.05.

2.4 Results
2.4.1 Generation of a transgenic mouse with Rac1 knockdown in the
SHF
To elucidate the role of Rac1 in the SHF, the Mef2c-Cre mouse was crossed to the
Rac1f/f mouse to generate Mef2c-Cre;Rac1f/f (Rac1SHF) offspring. Rac1SHF mice have
Rac1 gene specifically knocked down in SHF progenitors and their derivatives.
Embryonic samples were collected and loss of the Rac1 transcript was confirmed in
Rac1SHF hearts by quantitative RT-PCR. Rac1 mRNA expression was reduced by 51% in
the RV myocardium of E13.5 Rac1SHF compared to littermate Rac1f/f controls (Fig. 2.1A).
Immunostaining for Rac1 protein was also performed to further confirm the loss of
myocardial Rac1 expression in SHF derivatives. In P0 Rac1SHF hearts, robust staining for
Rac1 was observed in the LV. In the same P0 Rac1SHF heart section, the Rac1 signal
intensity was markedly decreased in the RV when compared to the LV (Fig. 2.1B). Ratio
of Rac1 to GAPDH protein was reduced by 40% in P0 Rac1SHF RV compared to
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littermate Rac1f/f controls as determined by Western blot analysis (Fig. 2.1C). These data
show that the Mef2c-Cre mediated recombination downregulates Rac1 expression in SHF
derivatives of the embryonic heart.
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Figure 2.1. Confirmation of Rac1 deletion in Rac1SHF hearts.
(A) Rac1 mRNA levels were significantly decreased in Rac1SHF RV compared to Rac1f/f
controls at E13.5, as measured by quantitative RT-PCR. **P<0.01 by unpaired Student’s
t test. (B) Immunostaining shows that Rac1 protein levels were reduced in P0 Rac1SHF
RV compared to the LV myocardium. (C) Western blot analysis of P0 RV showed a
significant decrease in Rac1 protein in Rac1SHF compared to Rac1f/f controls. *P<0.05 by
Mann-Whitney test. Scale bars: 100 µm (B, top panel), 20 µm (B, lower panels).

2.4.2 Deficiency of Rac1 in the SHF results in congenital heart
defects
The most prominent defect upon initial analysis of P0 Rac1SHF hearts was a gross
morphological abnormality in the overall shape of the heart. Instead of a distinct apex, all
P0 Rac1SHF hearts (28/28) had a deep interventricular groove and bifurcation of the two
ventricles, resulting in a bifid cardiac apex, a rare CHD in humans (Table 2.3, Fig. 2.2A,
B). Atrial septal defects (ASD) were observed in 82% (23/28) of Rac1SHF hearts but not
in littermate control Rac1f/f P0 hearts (0/19) (Table 2.3, Fig. 2.2C, D). Ventricular septal
defects (VSD) were seen in 100% (28/28) of P0 Rac1SHF hearts (Table 2.3, Fig. 2.2C,
D). Additionally, the RV myocardium had poor trabeculation and the compact
myocardium was significantly thinner in Rac1SHF hearts compared to littermate controls
(Fig. 2.2E-G and Table 2.3). These findings implicate a critical role for SHF Rac1
signaling in cardiac septation and RV development.
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Figure 2.2. Mef2c-Cre induced Rac1 deletion in SHF results in congenital heart
defects.
(A, B) Bifurcation between RV and LV (arrow) in P0 Rac1SHF hearts. (C, D) Atrial
septal defect (arrow head) and ventricular septal defect (arrow) were found in P0 Rac1SHF
hearts. (E-G) P0 Rac1SHF RV compact myocardium (double arrows) was significantly
thinner. ***P<0.001 by unpaired Student’s t test. RA, right atrium; LA, left atrium; RV,
right ventricle; LV, left ventricle. Scale bars: 100 µm (C, D), 50 µm (E, F).
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Table 2.3. Incidence of congenital heart defects in P0 Rac1SHF hearts.
Rac1f/f

Mef2c-Cre;Rac1f/+

Rac1SHF

(n=19)

(n=10)

(n=28)*

n

%

n

%

n

%

Normal

19

100

10

100

0

0

ASD

0

0

0

0

23
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VSD

0

0

0

0

28

100

Bifid apex

0

0

0

0

28

100

Defective RV

0

0

0

0

28

100

ASD, atrial septal defect; VSD, ventricular septal defect; RV, right ventricle. *21 alive
and 7 collected dead at P0. Since penetrance of congenital heart defects is 100% in
Rac1SHF hearts, statistical analysis is not necessary.

2.4.3 Rac1SHF hearts exhibit defective cardiomyocyte polarity
Cardiomyocyte organization and alignment were severely disrupted in P0 Rac1SHF hearts.
Cell membrane staining with wheat germ agglutinin (WGA) revealed rounded, spherical
shaped cardiomyocytes in Rac1SHF RV (Fig. 2.3B) compared to Rac1f/f RV, which had
elongated cardiomyocytes (Fig. 2.3A). Actin cytoskeleton organization was also severely
disrupted in Rac1SHF RV, as shown by phalloidin staining to mark F-actin filaments (Fig.
2.3D). Rac1SHF RV had an absence of long F-actin filaments while Rac1f/f RV
myocardium exhibited long, parallel running F-actin fibers (Fig. 2.3C). In addition,
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active (non-phosphorylated) β-catenin staining between cell junctions was also reduced in
E13.5 Rac1SHF RV compared to Rac1f/f RV (Fig. 2.3E and F). Overall, these data
strongly implicates disruption of cardiomyocyte polarity in Rac1SHF hearts.
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Figure 2.3. Rac1SHF hearts exhibit defective polarity.
(A, B) Wheat germ agglutinin (WGA) staining to mark cell membranes of P0 Rac1SHF
RV shows rounded cardiomyocytes compared to the elongated cells of littermate
controls. (C, D) Phalloidin staining to mark F-actin shows disorganization in cellular
structure and a deficiency in long actin filaments in the Rac1SHF RV. (E, F) Active (nonphosphorylated) β-catenin staining is reduced at cell-cell junctions in E13.5 Rac1SHF RV.
White arrows indicate cell adhesion. Scale bars: 20 µm (A-D), 10 µm (E, F).

2.4.4 Expression of Scrib protein is lost in Rac1SHF hearts
Scrib, the mouse homolog of the Drosophila protein Scribble, is a component of the PCP
pathway. Immunostaining shows Scrib protein was expressed mainly in the lower part of
RV and the cardiac apex in Rac1f/f hearts (Fig. 2.4A-B, E-F), and the number of Scrib+
cells was about 10 times higher in E15.5 than E12.5 Rac1f/f hearts (Fig. 2.4I-J). Notably,
Scrib expression was almost absent in both E12.5 and E15.5 Rac1SHF hearts (Fig. 2.4CD, G-H) and the number of Scrib+ cells was significantly decreased in Rac1SHF hearts
compared to littermate controls (Fig. 2.4I-J). The loss of Scrib expression implicates
disruption of the PCP pathway and further supports a failure to establish cardiomyocyte
polarity in Rac1SHF hearts.
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Figure 2.4. Decreased Scrib protein expression in Rac1SHF hearts.
(A-D) Scrib immunostaining was performed on E12.5 paraffin sections. Arrows indicate
Scrib protein expression. B and D are magnifications of box in A and C, respectively. (EH) Scrib immunostaining was performed on E15.5 paraffin sections. Arrows indicate
Scrib protein expression. F and H are magnifications of box in E and G, respectively. (I,
J) Number of Scrib positive cells was significantly decreased in E12.5 and E15.5
Rac1SHF hearts. n=3 hearts per group, *P=0.05 by Mann-Whitney test. Scale bars: 100
µm (A, C, E, G), 20 µm (B, D, F, H).

2.4.5 Rac1 is required for lamellipodia formation and cardiomyocyte
migration
Cell migration is a fundamental process of gastrulation, morphogenesis and
formation of organs and tissues during development.22 To determine whether Rac1 plays
a migratory role in SHF derived-cells, RV from E12.5 Rac1SHF;mTmG and control
Mef2c-Cre;Rac1f/+;mTmG control hearts were isolated and explants cultured on collagen
gels for six days. The mTmG global double-fluorescent Cre reporter mouse expresses
membrane-targeted Tomato (mT) before Cre-mediated excision and membrane-targeted
GFP (mG) after excision of mT.18 Thus all SHF-derived cells in Rac1SHF;mTmG and
Mef2c-Cre;Rac1f/+;mTmG are GFP+. It was observed that Mef2c-Cre; Rac1f/+;mTmG
control explants had both non-SHF derived (mT - labeled) and SHF-derived (mG labeled) cells migrating out from the RV explant by day six (Fig. 2.5A-C). In contrast,
Rac1SHF;mTmG explants only had non-SHF derived cells (mT - labeled) migrating out
from the RV explant and very little to no SHF-derived (mG - labeled) cell migration (Fig.
2.5D-F). The migration defects observed in the Rac1SHF;mTmG RV explants indicate that
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Rac1 regulates migration of SHF-derived progenitor cells, likely through actin
organization controlled by the WAVE and Arp2/3 pathway downstream of Rac1.23 A
significant decrease was found in Abi1, WAVE2, Arp2 and Arp3 expression, components
of the WAVE and Arp2/3 complex, in E13.5 Rac1SHF RV compared to littermate controls
(Table 2.4). To further assess cell migration, scratch assays were performed on neonatal
cardiomyocytes infected with adenoviral constructs of β-galactosidase (Ad-βgal) or
dominant negative Rac1 (Ad-Rac1N17). It was observed that 24 hours after scratch, Adβgal-treated cardiomyocytes were aligned perpendicular to the scratch edge and had
projections along the scratch edge, indicative of actin organization and lamellipodia
extension (Fig. 2.5G). In contrast, no projections and lamellipodia formation were
observed in Ad-Rac1N17 cardiomyocytes and the cells were disorganized and arranged
in a random orientation along the scratch edge (Fig. 2.5H). Overall, these findings
implicate Rac1 in the regulation of cell migration and lamellipodia extension in
cardiomyocytes.
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Figure 2.5. Rac1 deficiency results in defective cell migration and lamellipodia
formation.
(A-C) E12.5 RV explant cultures of Mef2c-Cre;mTmG;Rac1f/+ hearts have both SHFderived (mG) and non-SHF-derived (mT) migrating cells. (E-F) E12.5 RV explant
cultures of Rac1SHF;mTmG hearts have only non-SHF-derived (mT) migrating cells
without any SHF-derived migrating cells (mG). (G-H) Scratch assays of adenoviral
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infected neonatal cardiomyocytes show cellular projections and lamellipodia extensions
(arrows) beyond the scratch edge in Ad-βgal treated cells and none in Ad-Rac1N17
treated cells 24 hours post-scratch. Dotted white line indicates scratch edge. Shown are
representative images from 3 independent experiments.
Table 2.4. Real-time PCR analysis of gene mRNA levels in E13.5 Rac1SHF RV.
Gene

Rac1f/f

Rac1SHF

P Values

Nkx2.5

0.0583 ± 0.00423 (n=6)

0.0462 ± 0.00467 (n=6)

0.0320

Gata4

0.0410 ± 0.00206 (n=6)

0.0299 ± 0.00405 (n=6)

0.0338

Tbx5

0.0124 ± 0.00043 (n=8)

0.0090 ± 0.00135 (n=8)

0.0320

Hand2

0.0315 ± 0.00281 (n=6)

0.0211 ± 0.00116 (n=6)

0.0065

Tbx20

0.0428 ± 0.0038 (n=6)

0.0331 ± 0.00423 (n=8)

0.1256

Abi1

0.0268 ± 0.00215 (n=8)

0.0177 ± 0.00341 (n=8)

0.0404

WAVE2

0.1174 ± 0.00902 (n=8)

0.0756 ± 0.0140 (n=8)

0.0247

Arp2

0.0246 ± 0.00239 (n=8)

0.0167 ± 0.00109 (n=8)

0.0098

Arp3

0.1306 ± 0.00639 (n=8)

0.0901 ± 0.0109 (n=8)

0.0063

β-actin

0.2977 ± 0.0395 (n=6)

0.2220 ± 0.0298 (n=6)

0.1534

Data are ratios to 28S and presented as mean ± SEM. Significance in gene expression
difference between Rac1SHF and Rac1f/f littermates analyzed by unpaired Student’s t test.
P<0.05 was considered statistically significant. No significant differences were found in
Tbx20 and β-actin mRNA expression.
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2.4.6 Rac1SHF cardiomyocytes are shortened and rounded
Neonatal cardiomyocyte cultures from Rac1SHF RV tissues showed that these cells had
disrupted actin organization as indicated by phalloidin staining and the absence of distinct
cell projections compared to Rac1f/f cardiomyocytes. Interestingly, patterning of α-actinin
seemed to be disrupted as well in Rac1SHF cardiomyocytes (Fig. 2.6A, B). Measurement
of cardiomyocyte long axis length revealed significantly shorter Rac1SHF cardiomyocytes
compared to littermate control cardiomyocytes (Fig. 2.6E). Additionally, neonatal
Rac1SHF cardiomyocytes were rounded compared to control Rac1f/f cardiomyocytes,
which had an elongated morphology (Fig. 2.6C, D). No rounded cardiomyocytes were
found in Rac1f/f cultures while over 40% of Rac1SHF cardiomyocytes exhibited a rounded
morphology (Fig. 2.6F). These data strongly support the role of Rac1 in regulating
elongation and polarization of cardiomyocytes.
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Figure 2.6. Cells are rounded and cell length is reduced in cultured neonatal
Rac1SHF cardiomyocytes.
(A, B) Phalloidin and α-actinin staining of neonatal cardiomyocytes show defective
cellular organization and projection formation in Rac1SHF cells. (C, D) Rac1SHF
cardiomyocytes are a spherical shape compared to Rac1f/f controls. (E, F) Long axis
measurements of Rac1SHF cardiomyocytes showed that these cells are significantly
shorter and are more spherical compared to Rac1f/f controls. n=3 independent cultures per
group, * P=0.05 by Mann-Whitney test (E). Since penetrance of round cardiomyocyte is
0% in Rac1f/f cultures, statistical analysis is not necessary (F). Scale bars: 10 µm (A, B),
20 µm (C, D).

2.4.7 Contribution of SHF progenitors to Rac1SHF hearts is decreased
Histological analysis showed that a deep fissure between the RV and LV was observed in
E11.5 Rac1SHF hearts while this was not evident and the early muscular interventricular
septum was beginning to form in littermate control hearts (Fig. 2.7A, B). At E12.5,
bifurcation of the RV and LV in Rac1SHF hearts continued to be present (Fig. 2.7C, D)
and by E15.5 a distinct apex was formed in control hearts while Rac1SHF hearts continued
to have a deep cleft separating the ventricles (Fig. 2.7E, F). Fate-mapping with the
mT/mG global double-fluorescent Cre reporter mouse18 was performed to follow the
developmental progression of the SHF progenitors. A deficiency in the SHF lineage
contributing to the developing E11.5 Rac1SHF;mTmG hearts was evident, especially in the
early forming muscular interventricular septum between the RV and LV (Fig. 2.7G, H).
At E12.5 and E15.5, the interventricular septum in Rac1SHF;mT/mG hearts had a major
deficiency of SHF-derived cells, leading to formation of a bifid apex (Fig. 2.7I-L). These
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findings implicate a critical role of SHF Rac1 signaling in muscular interventricular
septum formation.

Figure 2.7. Deficient SHF progenitor contribution to Rac1SHF hearts.
(A-F) H/E staining of E11.5, E12.5 and E15.5 heart sections shows defective
interventricular septum formation (arrow) in Rac1SHF hearts, leading to a bifid cardiac
apex. (G-L) Fate mapping with mT/mG reporter shows a decreased SHF progenitor
contribution to the interventricular septum (arrow) in Rac1SHF hearts. Paraffin sections
were immunostained with anti-GFP. Scale bars: 100 µm (A-J), 200 µm (K, L).
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2.4.8 Rac1 promotes cell survival in SHF-derived myocardium
Aberrant apoptosis or decreased proliferation in the SHF may contribute to CHDs. To
determine whether an abnormality in proliferation was a factor in Rac1SHF hearts,
phosphohistone-H3 (pHH3) protein staining was performed on E11.5 heart sections (Fig.
2.8A-F). No differences in proliferation were observed between Rac1SHF and Rac1f/f
control hearts (Fig. 2.8G). Next, we stained for cleaved caspase-3 (the active form of
caspase-3) on E11.5 heart sections to detect cell apoptosis (Fig. 2.9A-D). Cleaved
caspase-3 staining was quantified as a percentage to the total number of cells. E11.5
Rac1SHF hearts had significantly higher levels of apoptosis in the RV compared to
littermate controls (Fig. 2.9E, P<0.05). Similarly, increased apoptosis was also observed
in the interventricular septum of E11.5 Rac1SHF hearts (Fig. 2.9B, D, E, P<0.05). No
significant difference in apoptosis was observed in the LV between E11.5 Rac1SHF and
control hearts (Fig. 2.9E, P=0.27). Together, this data defines a requirement for Rac1 in
cell survival but not proliferation in the development of SHF-derived cardiac structures.
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Figure 2.8. Phospho histone H3 (pHH3) protein staining to assess cell proliferation
in E11.5 Rac1SHF hearts.
(A-F) Representative pHH3 staining in transverse heart sections. Arrows indicate
positive signals. Scale bars: 20 µm. (G) No significant differences in cell proliferation
were found between E11.5 Rac1SHF and Rac1f/f hearts. n=3 hearts per group.
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Figure 2.9. Increased apoptosis in Rac1SHF RV and interventricular septum.
(A-D) E11.5 heart sections were immunostained with cleaved caspase-3 antibody to mark
apoptotic cells. Arrows indicate positive signals. B and D are magnifications of the box in
A and C, respectively. (E) Quantification of apoptosis in RV, LV and the cardiac septum.
* P<0.05 vs. corresponding Rac1f/f by Mann-Whitney test. Scale bars: 100 µm (A, C), 10
µm (B, D). (F) The proposed pathway of Rac1 signaling in SHF derivatives during
embryonic heart development. Rac1 regulates actin organization to promote
cardiomyocyte polarity and cell migration. Additionally, Rac1 promotes cell survival and
the expression of cardiac developmental genes. Overall, these effects of Rac1 contribute
to normal RV and septal development of the heart.

2.4.9 Downregulation of transcription factors
Heart development is regulated by a complex network of transcription factors,
which interact synergistically and in a dose-dependent manner to activate target genes.24
To address the genetic pathways regulated by Rac1 signaling in the SHF, we analyzed
known transcription factors important for heart development. Expression levels of Gata4,
Nkx2.5 and Tbx5 mRNA were significantly decreased in the RV of E13.5 Rac1SHF
compared to Rac1f/f hearts (Table 2.4). Hand2 and Tbx20 are two transcription factors
shown to be expressed predominantly in the RV and regulate RV development.25,

26

Hand2 expression was significantly decreased in the RV of E13.5 Rac1SHF compared to
Rac1f/f hearts (Table 2.4). However, no significant differences were found in Tbx20
expression between Rac1f/f and Rac1SHF RV (Table 2.4). Taken together, these findings
indicate that transcriptional regulation of RV development was severely disrupted in the
Rac1SHF hearts.
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2.5 Discussion
The present study was carried out to examine the role of Rac1 in SHF progenitors.
Using the SHF specific Mef2c-Cre mouse line to delete Rac1 in SHF progenitors and
derivatives, we demonstrated that a Rac1 deficiency in the SHF leads to 100% penetrance
of CHDs including septal defects, thin RV myocardium and defective trabeculation and
most notably, a bifid cardiac apex. Our data showed for the first time that Rac1 signaling
is critical to cardiomyocyte polarity and embryonic heart development with contributions
of cell migration, survival and cardiac gene expression (Fig. 2.9F).
Rac1 has been shown to be a downstream effector of the PCP pathway by
modulating the cytoskeleton and regulating actin dynamics in Drosophila and Xenopus.9,
27

However, the role of Rac1 in mammalian cardiomyocyte polarity and heart

development is not known. Studies have shown that disruption of the PCP pathway in
mice by deletion of Scrib resulted in cellular disorganization, defective trabeculation, thin
myocardium and chamber septation defects,6 which are strikingly similar to the defects
observed in this study and strongly supports a disruption of PCP signaling in Rac1SHF
hearts. Interestingly, we observed that Scrib protein expression pattern is most abundant
in the RV and interventricular septum junction during embryonic heart development.
Notably, Scrib protein expression in this distinct cardiac tissue area is lost in Rac1SHF
hearts. We postulate that cardiomyocytes at the RV and interventricular junction must be
highly polarized and oriented to align with the forming cardiac apex. The rounded, nonpolarized and disorganized Rac1SHF cardiomyocytes are likely unable to bridge the RV
and interventricular junction to unify the two ventricles to form a cardiac apex resulting
in bifurcation of the muscular septum. In addition, a decrease in cell number due to
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increases in apoptosis in this area may also contribute to the development of bifid apex. It
has been reported that genetic deletion of transcription factor Ets1 also results in VSD
and bifid cardiac apex.28 However, another group using the same Ets1 knockout mouse
did not observe a bifid cardiac apex.29 This makes the role of Ets1 still unclear in the
formation of a bifid cardiac apex. Recorded cases of bifid cardiac apex in humans are
very rare and have usually been reported concomitantly with other congenital heart
anomalies including ASD, VSD and defective RV development,30,

31

which are very

similar to the type of defects that were observed in Rac1SHF hearts. Thus, it is possible
that the bifid cardiac apex and associated cardiac defects found in humans could be
partially associated with abnormalities in Rac1 signaling and defects in cardiomyocyte
polarity during embryonic heart development.
It is well established that actin is the most abundant cytoskeleton protein and
plays a critical role in controlling cell orientation, cell shape and migration. Rac1 is an
important regulator of actin polymerization, ruffle formation, lamellipodia extension and
migration in numerous cell types.7 Rac1 is known to activate the Wiskott-Aldrich
syndrome protein (WASP)-family verprolin-homologous protein (WAVE) complex,
which is recruited to the plasma membrane and regulates the actin cytoskeleton through
the actin-related protein-2/3 (ARP2/3) complex. ARP2/3 associates with actin filaments
to promote formation of new filaments from the sides of existing filaments, creating a
dendritic network of branched actin filaments to extend lamellipodia and propel cells
forward during migration.32,

33

The combined defects in cell polarity, morphology,

lamellipodia formation and actin organization observed in SHF-derived cells led to an
overall inhibition of cardiomyocyte migratory ability in Rac1SHF embryos. Furthermore,
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Rac1 has been shown to promote cell survival by activation of the PI3K/ Akt pathway.3436

Decreased migration ability and an increased rate of apoptosis in SHF-derived cells

likely concomitantly contribute to an overall deficiency in SHF contribution to the
developing Rac1SHF heart.
Numerous studies have found that Rac1 can regulate gene expression through
different pathways. Interestingly, it has been shown that Rac1 can activate the canonical
Wnt pathway by promoting nuclear accumulation of β-catenin, the effector of the Wnt
pathway.37, 38 Ai el al. showed that deletion of β-catenin in the SHF led to abnormalities
in development of the RV and interventricular septum,39 very similar to the defects
observed in Rac1SHF mice in the present study. However, whether the defects were also
due to loss of β-catenin cell-cell adhesion was not addressed in their study. Our data
showed a loss of β-catenin cell adhesions in the Rac1SHF RV myocardium, supporting a
defect in polarity and places non-canonical Wnt signaling as the main driver of the
cellular and morphological defects observed. Our data is supported by Abhul-Ghani et al,
where they showed that non-canonical Wnt, which is highly active during cardiogenesis,
antagonizes the canonical Wnt pathway.40 However, the contribution of canonical Wnt
signaling cannot be ruled out in our study since it has been shown to play a role in
specification and expansion of early SHF progenitors.41 Rac1 can also promote gene
expression through NF-κB and JNK pathways.42, 43 Our data showed that Rac1SHF hearts
have decreased expression of Gata4, Tbx5, Nkx2.5 and Hand2 transcription factors in the
developing RV. Thus, it is plausible that a Rac1 deficiency in the SHF will lead to
decreased NF-κB and/or JNK signaling and down-regulation of key cardiac transcription
factors during embryonic heart development. Tbx20 acts in a dose-sensitive manner as an

102

essential regulator of outflow tract, cardiac valve and RV development.26 However, no
significant down-regulation of Tbx20 expression was found in the Rac1SHF hearts. A
hierarchy of distinct cardiac transcription factor regulation exists in the developing
heart.44,

45

Our data suggests that Rac1 regulates a distinct network of cardiac

transcription factors that do not include Tbx20 in SHF-derivatives. Future studies will be
necessary to determine what exact downstream pathways Rac1 regulates in the SHF to
promote cardiac gene expression.
Tbx5 is essential in the SHF for atrial septation,46 despite it is predominately
expressed in the LV during early heart development.47, 48 In addition, Später et al recently
challenged the view of Tbx5 as a classical FHF marker,49 where they showed an overlap
of expression pattern between the posterior end of the Tbx5-positive FHF domain and the
Isl1-positive SHF domain, thus implicating a role for Tbx5 in the SHF. Our data is
compatible with the studies on Tbx5 from Nadeau et al,50 and Xie et al,46 where they
showed that Gata4 and Tbx5 co-operatively regulate atrial septum development and
haploinsufficiency of Tbx5 in the SHF results in ASDs.
Although further investigations are required to analyze potential RAC1 gene
mutations in humans with bifid cardiac apex, the present study has shown that SHF Rac1
is critical to septal and RV development and deficiencies in SHF Rac1 can give rise to
bifid cardiac apex along with the associated CHDs. Our data is the first to show Rac1 as
an essential regulator of cardiomyocyte polarity during heart development and to provide
a possible mechanism for how bifid cardiac apex arises. Establishment of cellular polarity
is essential for the processes regulating cell morphology, lamellipodia formation and cell
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migration in the developing embryo and this seems to be especially critical in formation
of a distinct cardiac apex during embryonic heart development.

2.6 Footnotes
This work was funded by operating grants (to Q.F.) from Canadian Institutes of Health
Research (CIHR). C.L. was supported by a Natural Sciences and Engineering Research
Council (NSERC) Scholarship. Q.F. is a Heart and Stroke Foundation of Ontario Career
Investigator.
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Rac1 signaling is required for anterior second heart field cellular organization and
cardiac outflow tract development
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Chapter 3
3.1 Chapter Summary
The small GTPase Rac1 regulates diverse cellular functions, including both apicobasal
and planar cell polarity (PCP) pathways. However, its role in cardiac outflow tract (OFT)
development remains unknown. In the present study, we aimed to examine the role of
Rac1 in the anterior second heart field (SHF) splanchnic mesoderm and subsequent OFT
development during heart morphogenesis. Using the Cre/loxP system, mice with an
anterior SHF-specific deletion of Rac1 (Rac1SHF) were generated. Embryos were
collected at various developmental time points for immunostaining and histological
analysis. Intrauterine echocardiography was also performed to assess aortic valve blood
flow in E18.5 embryos. The Rac1SHFsplanchnic mesoderm exhibited disruptions in SHF
progenitor cellular organization and proliferation. Consequently, this led to a spectrum of
OFT defects along with aortic valve defects in Rac1SHFembryos. Mechanistically, it was
found that the ability of the Rac1SHF OFT myocardial cells to migrate into the proximal
OFT cushion was severely reduced. In addition, expression of the neural crest
chemoattractant semaphorin, Sema3c, was decreased. Lineage tracing showed that
anterior SHF contribution to the OFT myocardium and aortic valves was deficient in
Rac1SHF hearts. Furthermore, functional analysis with intrauterine echocardiography at
E18.5 showed aortic valve regurgitation in Rac1SHFhearts, which was not seen in control
hearts. Disruptions to Rac1 signaling in the anterior SHF results in aberrant progenitor
cellular organization and defects in OFT development. Our data show Rac1 signaling as a
critical regulator of cardiac OFT formation during embryonic heart development.
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3.2 Introduction
Cardiac outflow tract (OFT) defects account for approximately one third of all
congenital heart defects (CHDs) reported in human births and often requires intervention
within the first year of life. Even after surgical correction, risk of morbidity and mortality
from OFT defects remains high.1, 2 However, the molecular mechanisms underlying OFT
defects are not well defined. Understanding the developmental mechanisms of OFT
formation is crucial for new insights into improving diagnostics and designing
therapeutic approaches for CHD patients.
Cell polarity is the asymmetrical organization of cell membrane proteins,
intracellular organelles and actin cytoskeleton that can influence cell fate and specialized
functions such as migration and proliferation.3 Establishment of polarity is a critical step
in a multitude of developmental events, including formation of the OFT.4, 5 The intricate
process of OFT development involves coordination and interactions between two distinct
cell types, second heart field (SHF) progenitors and cardiac neural crest cells.6 The SHF
progenitors give rise to the myocardial and endothelial cells of the OFT, semilunar
valves, along with vascular smooth muscle cells at the base of the aorta and pulmonary
trunk. Neural crest cells contribute to septation of the OFT and remodeling of the aortic
arches and semilunar valves.7,

8

At approximately E8.5, cardiac neural crest cells will

delaminate from the neural tube, migrate into the pharyngeal region and become closely
apposed with SHF progenitors in the dorsal pericardial wall.9 SHF cells form an
apicobasally-polarized epithelium in the splanchnic mesoderm and maintenance of this
apicobasal polarity is crucial for heart tube elongation and OFT morphogenesis.10 Planar
cell polarity (PCP), which is orthogonal to apicobasal polarity, has also been shown to be
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a critical regulator of the SHF as tissue-specific deletion of core PCP genes, Vangl2 and
Dishevelled1/2, recapitulates the spectrum of OFT defects reported in the full-body
mutants.11, 12 Recent studies have suggested that apicobasal polarity and PCP signaling
are interconnected where crosstalk occurs to maintain cellular polarity and overall tissue
architecture.13, 14
Rac1 is a small signaling GTPase from the Rac subfamily of Rho GTPases and
has been implicated in both apicobasal polarity and PCP signaling pathways.15, 16 Rac1
acts as a pleiotropic effector of numerous cellular processes including regulation of the
actin cytoskeleton and overall cell shape and morphology, which are critical components
of cell polarity.17 The role of Rac1 in cell polarity has been shown by orientation of hair
cells in the cochlea, convergent extension cellular movements and anterior-posterior body
axis specification during development.18-20 We have recently demonstrated Rac1 to be a
critical regulator of cardiomyocyte polarity and cardiac septation during heart
development.21 However, the role of Rac1 in OFT development is unknown. The SHF
progenitors in the dorsal splanchnic mesoderm can be further subdivided into two
subdomains: the anterior and the posterior SHF.22, 23 A Mef2c-Cre transgenic mouse has
been developed that drives expression of Cre recombinase solely in the anterior
subdomain of the SHF, which contributes to the right ventricle and the OFT. Specifically,
the Cre recombinase sequence in the Mef2c-Cre transgenic mouse is under regulatory
control of an anterior heart field specific enhancer and promoter, which was first
discovered by Dodou et al.8, 24 In order to study the role of Rac1 in OFT formation, we
generated an anterior SHF-specific deletion of Rac1 using the Mef2c-Cre transgenic
mouse as described previously.21 We show that Rac1 signaling in the anterior SHF is
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critical for progenitor cellular organization in the splanchnic mesoderm and disruptions in
Rac1 signaling result in a spectrum of OFT defects, along with aortic valve defects.
Furthermore, we showed that a Rac1 deficiency, restricted to the anterior SHF, leads to
neural crest cell migration defects.

3.3 Methods
3.3.1 Mice
Rac1f/f (Stock #5550) and mT/mG C57BL/6 mice (Stock #7676) were purchased from
Jackson Laboratory, Bar Harbor, Maine.24,

25

The anterior SHF specific Mef2c-Cre

transgenic mice were rederived from embryos obtained from the Mutant Mouse Regional
Resource Centers (MMRRC, Chapel Hill, North Carolina).8 A breeding program to
generate C57BL/6 Mef2c-Cre;Rac1f/f (Rac1SHF) mice was carried out and genotyping was
performed as described previously.21 All mouse experiments and procedures were
approved by the Animal Use Subcommittee at the University of Western Ontario in
accordance with the guidelines of the Canadian Council of Animal Care.

3.3.2 Fate Mapping Analysis
Fate mapping analysis was performed using Mef2c-Cre and the mT/mG global doublefluorescent Cre reporter mice to trace the anterior SHF and derivatives.8, 25 A breeding
strategy was carried out to generate Mef2c-Cre;mT/mG and Mef2c-Cre;Rac1f/f;mT/mG
(Rac1SHF;mT/mG) mice. The mT/mG mice possess loxP sites on either side of the
membrane-targeted Tomato (mT) cassette with a membrane-targeted green fluorescent
protein (GFP) cassette downstream. Before Mef2c-Cre mediated excision, mT (red
fluorescence) is expressed in all cells. After Mef2c-Cre mediated excision, the mT
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cassette is cleaved out and membrane-targeted GFP (mG) is expressed in all SHF
progenitors and SHF-derived tissues.

3.3.3 Histological Analysis
Neonatal and embryonic samples were fixed overnight in 4% paraformaldehyde at 4°C,
dehydrated and embedded in paraffin. Embryos were serially sectioned at 5 µm thick
sections with a Leica RM2255 microtome and sections were mounted onto positively
charged albumin/glycerin coated slides as previously described.21 Slides underwent a
dewaxing process, stained with hematoxylin and eosin (H/E) or picrosirius red for
morphological analysis. Images were captured with an Observer D1 light microscope
(Zeiss, Germany).

3.3.4 Immunohistochemistry
For immunohistochemical staining on paraffin sections, samples underwent a deparaffin
process and antigen retrieval was performed in sodium citrate buffer as described
previously.21 The primary antibodies used for immunostaining include phosphohistoneH3 (phospho S10, Abcam), GFP (Abcam), α-actinin (Sigma), Sema3c (Santa Cruz) and
AP2α (Santa Cruz). Slides were then incubated with biotinylated secondary antibody
followed by incubation with avidin and biotinylated HPR from the Santa Cruz
ImmunoCruz ABC staining system kit. Antigen was visualized with diaminobenzidine
(DAB) substrate solution and slides were counterstained with hematoxylin. All images
were captured with Zeiss Observer D1 microscope using AxioVision Rel 4.7 software.
For frozen sections, embryos were fixed for one hour in 4% paraformaldehyde,
cryoprotected in 30% sucrose and embedded in FSC22 frozen section media (Leica).
Embryos were sectioned in a sagittal orientation at 10 µm thick and immunostained with
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the primary antibodies for Scrib (Santa Cruz), aPKCζ (Santa Cruz), and active (nonphosphorylated) β-catenin (Cell Signaling). Additional staining was also performed with
AlexaFluor 488 phalloidin (Life Technologies), AlexaFluor 647 wheat germ agglutinin
(Invitrogen) and Hoechst 33342 (Invitrogen). A Zeiss LSM 510 Duo microscope with
ZEN 2012 software (Zeiss, Germany) located at the Biotron Experimental Climate
Change Research Center at Western University, London, Ontario was used to obtain
confocal images.

3.3.5 Intrauterine Echocardiography
Echocardiography was performed on pregnant mice using Vevo 2100 (VisualSonics,
Canada).26 Briefly, pregnant mice were anaesthetized with isoflurane and fur was shaved
from the abdomen to better image embryos. A map was drawn of the location of embryos
relative to each other to facilitate harvesting of embryos after intrauterine
echocardiography. A dynamically focused 40 MHz probe was used to obtain 2dimensional images of embryonic hearts in short-axis view. Diastolic and systolic left
ventricular internal diameters (LVID) were measured from M-mode recordings.
Calculations were performed as followed: ejection fraction (EF, %) = [(LVIDd)3 (LVIDs)3]/(LVIDd)3×100. Fractional shortening (FS, %) = (LVIDd-LVIDs)/LVIDd×100.
To assess aortic valve regurgitation, the transducer was aligned with the long axis of the
heart and Color flow and Pulsed-Wave Doppler were used to visualize direction of blood
flow in the aorta. In Color Doppler mode, red indicated flow towards the transducer and
blue indicated blood flow away from the transducer. Pulsed-Wave Doppler mode was
used to measure direction of blood flow, bloodflow velocity and duration of the aortic
valve regurgitation.27
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3.3.6 Statistical Analysis
Data are presented as means ± SEM. When data passed a normality test, an unpaired
Student’s t test was employed to test for significance. Nonparametric Mann-Whitney test
was used when samples size was 3 per group. Differences were considered significant at
P<0.05.

3.4 Results
3.4.1 Early defects in the splanchnic mesoderm of Rac1SHF
Lineage tracing analysis using Mef2c-Cre and mT/mG global double fluorescent
reporter mice revealed that lack of Rac1 in the anterior SHF resulted in defects in
splanchnic mesoderm at E9.5. Large acellular spaces were observed between GFP+ SHF
progenitor cells and less cells resided in the overall splanchnic mesoderm region of E9.5
Rac1SHF;mTmG

embryos

(Fig.

3.1C,

D)

compared

to

littermate

Mef2c-

Cre;mTmG;Rac1f/+ controls (Fig. 3.1A, B). The number of GFP+ SHF progenitor cells in
the splanchnic mesoderm was significantly less in Rac1SHF embryos compared to controls
(Fig. 3.1E). Before differentiation, the SHF progenitor population in the splanchnic
mesoderm is highly proliferative.28 To analyze SHF proliferation, phosphohistone-H3
(pHH3) immunostaining was performed on sagittal sections of E9.5 embryos (Fig. 3.1F,
G). The proliferation rate of SHF progenitors in E9.5 Rac1SHF was significantly reduced
compared to littermate Rac1f/f controls (Fig. 3.1H). This reduced proliferation rate likely
resulted in a reduced number of SHF progenitors within the Rac1SHF splanchnic
mesoderm. Overall, these results define a requirement for Rac1 signaling in SHF
progenitor cell proliferation.
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Figure 3.1. Early defects in E9.5 Rac1SHF splanchnic mesoderm.
Lineage tracing with Mef2c-Cre;mT/mG showed a decreased number of GFP+ SHF cells
along with large acellular spaces in the splanchnic mesoderm of Rac1SHF;mT/mG (C, D)
compared to littermate control embryos (A, B). The number of GFP+ SHF progenitor
cells in the splanchnic mesoderm was significantly reduced in E9.5 Rac1SHF;mT/mG
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compared to controls (E). Immunostaining for phospho-histone H3 (pHH3) in the
splanchnic mesoderm (F, G) showed a reduced proliferation rate in Rac1SHF SHF
progenitors compared to Rac1f/f controls (H). *P<0.05, **P<0.01 by Student’s t-test, n=45 embryos per group. Scale bars: 100 µm (A, C), 10 µm (B, D), 20 µm (F, G). OFT,
outflow tract; IFT, inflow tract; SpM, splanchnic mesoderm.

3.4.2 Disruption of cell shape and organization in Rac1SHF splanchnic
mesoderm
SHF progenitor cells possess apicobasal polarity which form a polarized epithelial
layer in the dorsal pericardial wall.10 Our data show that cellular organization was
severely disrupted in the E9.5 Rac1SHF anterior SHF progenitors (Fig. 3.2). The
basolateral and apical domains of the Rac1f/f splanchnic mesoderm were marked by
Scribble and aPKCζ, respectively. In addition, the SHF progenitors have a cuboidal
shape, with neighbouring cells aligned with one another to form the epithelial layer (Fig.
3.2A-C). In comparison, organization of the Rac1SHF SHF epithelial layer was lost and
SHF progenitor cells exhibited a rounded morphology. Cellular organization in the E9.5
Rac1SHF splanchnic mesoderm was disturbed where the basal domains of neighbouring
SHF progenitors were no longer aligned with one another and the cells displayed a
rounded morphology (Fig. 3.2D-F). Orientation of the long axis of the anterior SHF
progenitor cells were measured relative to the axis of the dorsal pericardial wall (Fig.
3.2G) and it was found that E9.5 Rac1SHF SHF progenitor cells had a random,
unorganized orientation compared to Rac1f/f controls. Rac1f/f SHF progenitors had an
orientation range of 62 – 89.5°, averaging 78.5° relative to the dorsal pericardial wall
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axis. In comparison, Rac1SHF SHF progenitors oriented with a significantly smaller angle
averaging 41.8° relative to the dorsal pericardial wall axis (Fig. 3.2H). Cell-cell
junctions, as marked by active (non-phosphorylated) β-catenin expression, was disrupted
in the E9.5 Rac1SHF splanchnic mesoderm compared to Rac1f/f controls, further
supporting a disruption in SHF progenitor cell organization (Fig. 3.2I, J). Taken together,
these findings support a critical role of Rac1 signaling in regulation of overall SHF
progenitor cell shape and maintenance of cell organization.
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Figure 3.2. Disrupted apicobasal cell polarity and orientation in Rac1SHF splanchnic
mesoderm.
In E9.5 Rac1f/f SHF progenitors, the basolateral domain is marked by Scribble (B,
arrows) and the apical domain is marked by aPKCζ (A, arrowheads). The SHF
progenitors have a distinct cuboidal shape, forming an organized epithelial layer (C).
Polarity is disrupted in Rac1SHF SHF progenitors where the Scribble+ basal domains (E,
arrows) and aPKCζ+ apical domains (D, arrowheads) of individual cells are no longer
aligned with neighbouring cells due to the rounded morphology of the SHF progenitors
(F). C is an overlay of A and B. F is an overlay of D and E. The angle of E9.5 SHF
progenitor cell long axis (dashed line) was measured relative to the axis of the dorsal
pericardial wall (dashed arrow line) to obtain the degree of orientation (G). Images in G
are from C and F with an overlay of schematic axis and angle measurements. E9.5 Rac1f/f
SHF progenitor cells were approximately perpendicular to the dorsal pericardial wall
axis. E9.5 Rac1SHF SHF progenitors had a random range of orientation with an average of
41.8° (H). ***P<0.001 by Student’s t-test, n=4 each group. Active (non-phosphorylated)
β-catenin marked cell-cell junctions in E9.5 Rac1f/f SHF progenitors (I, arrows). In
comparison, cell-cell junctions were disrupted in E9.5 Rac1SHF SHF progenitors (J).
Scale bars: 10 µm (A-F, I-J).

3.4.3 Loss of Rac1 in the SHF results in shortened OFT and
myocardial defects of the OFT
Sufficient lengthening of the heart tube from SHF progenitors ensures
convergence of the inflow and outflow poles during cardiac looping. A shortened outflow
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tract alters looping and leads to arterial pole misalignment defects such as double outlet
right ventricle (DORV) and overriding aorta.29,

30

The sagittal length of the OFT was

measured at E10.5 (Fig. 3.3A, B) and it was found that the Rac1SHF OFT was
significantly shorter compared to controls (Fig. 3.3C). Closer analysis of the SHFderived OFT myocardium revealed a disorganized myocardial layer in E10.5 Rac1SHF
OFT compared to controls (Fig. 3.3D-G). Myocardial cells in the Rac1f/f OFT were
aligned with one another and had a general oval or cuboidal cell shape (Fig. 3.3D, F). In
contrast, myocardial cells in the Rac1SHF OFT were not as well aligned and the shapes of
the cells were not as distinctly oval or cuboidal (Fig. 3.3E, G). In addition, cell-cell
adhesion junction marked by β-catenin was generally disrupted in the myocardium of
E10.5 Rac1SHF OFT compared to Rac1f/f controls (Fig. 3.3H, I). Myocardial cells of
Rac1f/f OFT had distinct cell-cell borders with neighbouring myocardial cells and βcatenin was localized to the basolateral region. Basolateral localization of β-catenin was
disrupted in the myocardium of E10.5 Rac1SHF OFT. These results suggest an important
role of Rac1 in generating the cellular organization of the myocardial layer and
lengthening of the OFT.
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Figure 3.3. Defects in early Rac1SHF outflow tract development.
(A-C) Length of the OFT at E10.5 was measured in sagittal sections (A, B) and was
found to be significantly shorter in Rac1SHF compared to Rac1f/f controls (C). *P<0.05 by
Student’s t-test, n=4-5 each group. (D, E) Wheat germ agglutinin (WGA) staining to
mark cell membranes of SHF cells in the OFT at E10.5 show a disorganized myocardial
layer in Rac1SHF compared to Rac1f/f littermate controls. F and G are schematic diagrams
of D and E, respectively. (H, I) Active (non phosphorylated) β-catenin staining is reduced
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at cell-cell junctions in E10.5 Rac1SHF OFT myocardial cells. White arrows indicate cellcell adhesion sites. Dotted white lines indicate boundaries of the OFT myocardial layer in
D, E and H, I. Scale bars: 100 µm (A, B), 10 µm (D, E, H, I). Myo indicates
myocardium.

3.4.4 OFT defects in Rac1SHF hearts
Examination of Rac1SHF hearts revealed a spectrum of OFT defects from E14.5 to
P0 that was 100% penetrant (Table 3.1). The majority of the defects found were OFT
alignment defects. Over one third of Rac1SHF hearts (23/64) displayed DORV (Fig. 3.4AD) and over another one third (24/64) exhibited an overriding aorta (Fig. 3.4E, F).
Transposition of the great arteries (TGA) was found in one P0 Rac1SHF sample (Fig.
3.4G, H). In addition to defects in OFT alignment, defects in septation of the OFT
resulting in persistent truncus arteriosis (PTA) or common arterial trunk was observed in
9.4% (6/64) of Rac1SHF hearts (Fig. 3.4I, J). Narrowing of the great arteries was also
observed in Rac1SHF hearts including stenosis of the pulmonary artery (Fig. 3.4K, L) and
aortic atresia (Fig. 3.4M, N). In one case of aortic atresia in Rac1SHF hearts, aortic valves
were also severely malformed (Fig. 3.4O, P). In addition, we observed abnormalities in
aortic arch artery remodeling resulting in a retroesophageal right subclavian artery or a
vascular ring, a congenital defect in which vascular structures surround and constrict the
esophagus and trachea. This was evident in 18.8% (12/64) of Rac1SHF hearts and of the 12
samples that had a vascular ring, 3/12 had a right-sided aortic arch (Fig. 3.5A-F and
Supplemental Videos and Footnotes). Taken together, all of these data strongly support
a critical requirement for Rac1 signaling in anterior SHF progenitors for normal OFT
morphogenesis.

125

Figure 3.4. Spectrum of OFT defects found in E14.5 - P0 Rac1SHF hearts.
Double outlet right ventricle (DORV) was found in E15.5 Rac1SHF hearts (A-D). The
pulmonary artery (PA) connects to the RV in both Rac1SHF and Rac1f/f hearts (A, B). The
Rac1SHF aorta (arrow) incorrectly connects to the RV compared to Rac1f/f controls, where
the aorta connects to the LV (C, D). Overriding aorta, where the aorta is positioned
directly over a ventricular septal defect (arrow), was observed in Rac1SHF hearts (E, F).
Transposition of the great arteries (TGA) was found in one Rac1SHF sample where the
aorta and pulmonary artery openings were switched, which resulted in the aorta (Ao)
connecting to the RV in Rac1SHF and the pulmonary artery to the LV (G, H),
respectively. Persistent truncus arteriosus (PTA), where the common OFT is not divided
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into aorta and pulmonary, was observed in Rac1SHF hearts (I, J). Stenosis of the
pulmonary artery was observed in Rac1SHF hearts (K, L). Aortic atresia was observed in
Rac1SHF hearts (M, N) and in one sample with aortic atresia, distinct aortic valves were
absent (O, P). RA, right atrium; LA, left atrium. Scale bars: 100 µm.

Figure 3.5. Vascular rings in E15.5 Rac1SHF hearts.
A right-sided aortic arch (AA) was observed in Rac1SHF (D) hearts compared to Rac1f/f
controls (A). An aberrant retroesophageal right subclavian artery (SCA), which arose
from aortic arch, was observed next to the trachea (Tr) and esophagus (Eo) in Rac1SHF
hearts (E) compared to Rac1f/f controls (B). The SCA in Rac1SHF hearts joined with the
pulmonary artery (PA), forming a vascular ring (F) in Rac1SHF hearts compared to
controls (C). DA indicates dorsal aorta. Scale bars: 100 µm.
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Table 3.1. Outflow tract defects in Rac1SHF hearts (E14.5 – P0).

!

TGA

PTA

DORV

Overriding
aorta

Aortic
atresia

Vascular
ring

N=64

1

6

23

32

5

12

%

1.6

9.4

35.9

50

7.8

18.8

TGA, transposition of great arteries; PTA, persistent truncus arteriosus; DORV, double
outlet right ventricle. All 64 Rac1SHF hearts had one or more OFT defects. No OFT
defects were found in Rac1f/f hearts (N=36).

3.4.5 Myocardialization defects in Rac1SHF hearts
Myocardialization is a process where myocardial cells migrate and grow into the
flanking mesenchyme. At E12, myocardial cells of the OFT begin to invade the
neighbouring cushion mesenchyme. This leads to a gradual replacement of the
mesenchymal tissue with myocardium to form the muscular outlet septum by E17.31
Abnormalities in muscularization of the OFT cushions was observed in E12.5 Rac1SHF
hearts. The Rac1SHF OFT myocardium lacked a polarized morphology and did not extend
as far into the cushion mesenchyme compared to controls (Fig. 3.6A, B). Muscularization
of the proximal OFT septum is complete in P0 Rac1f/f control hearts as shown by αactinin positive muscle tissue separating the aorta from the RV (Fig. 3.6C). In P0
Rac1SHF hearts, the proximal OFT septum remained non-muscularized and remnant
collagen rich mesenchymal tissue remained (Fig. 3.6D), staining positive for picrosirius
red (Fig. 3.6E, F). Rac1SHF samples with defects in muscularization of the proximal OFT
septum also presented with OFT misalignment defects including overriding aorta and
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DORVs. These results further support a crucial role for Rac1 signaling in regulating
polarity, along with elongation and migration of cardiomyocytes during the process of
OFT myocardialization.
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Figure 3.6. Abnormalities in Rac1SHF OFT myocardialization.
E12.5 Rac1SHF OFT cardiomyocytes, marked by α-actinin immunostaining (B), exhibited
a blunted morphology instead of a polarized morphology and did not extend as far into
the OFT cushions compared to controls (A). Red arrows indicate invading
cardiomyocytes. The proximal OFT septum remained non-muscularized in P0 Rac1SHF
hearts (D), indicated by an absence of α-actinin staining (arrows in D) compared to
control (C) where the septum is muscularized (arrow in C). The non-muscularized
proximal OFT septum in Rac1SHF hearts (F) stained positive for picrosirius red (arrows in
F), indicating that this tissue remained mesenchymal compared to controls (E) which had
become muscularized (arrow in E). N=3 for each staining per group. Ao, aorta; RV, right
ventricle. Scale bars: 10 µm (A, B), 50 µm (C-F).

3.4.6 Decreased cardiac neural crest cell migration in Rac1SHF
The aortic arch artery and OFT septation defects observed in Rac1SHF hearts
suggests abnormal formation or remodeling of the arteries involving cardiac neural crest
cells. Semaphorin 3c (Sema3c) is a secreted glycoprotein part of the semaphorin protein
family, which plays a role in axon guidance.32 Sema3c is expressed in the OFT
myocardium and acts as a chemoattractant, navigating neural crest cells to the OFT.
Neural crest cells express the multimeric complexes of plexins and neuropilin, which are
the receptors that recognize semaphorin ligands.33 Interactions between SHF progenitors
and cardiac neural crest cells have been shown to be critical for development of the aortic
arches and semilunar valves.6, 7 Sema3c expression was analyzed in Rac1SHF hearts and
intensity of Sema3c protein staining in E11.5 Rac1SHF OFT myocardium was found to be
decreased compared to Rac1f/f controls (Fig. 3.7C, D, F). Along with this, the mRNA
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level of Sema3c, as measured by real-time PCR, was significantly reduced in Rac1SHF
hearts compared to littermate controls at E13.5 (Fig. 3.7G). Consequently, this would be
predicted to result in a reduction in the chemoattractant signal attracting the migrating
neural crest cells into the developing heart. The number of migrating cardiac neural crest
cells, marked by the transcription factor AP2α, was significantly decreased in the region
between the foregut and pericardial cavity in E10.5 Rac1SHF embryos (Fig. 3.7A, B, E).
Overall, these results suggest that disruption of Rac1 signaling in the SHF-derived OFT
myocardium leads to reduced expression of axonal guidance signals that attract migrating
neural crest cells into the developing OFT.
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Figure 3.7. Defects in neural crest cell contribution to OFT development in Rac1SHF
hearts.
(A, B) AP2α immunostaining was performed to mark neural crest cells in the pharyngeal
region of E10.5 samples. (C, D) Sema3c immunostaining (brown color) in Rac1SHF and
Rac1f/f OFT myocardium at E11.5. (E) The number of neural crest cells was significantly
reduced in E10.5 Rac1SHF pharyngeal arches compared to controls. (F) Intensity of
Sema3c staining in the E11.5 OFT myocardium was ranked on a scale from 1 to 5.
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Overall intensity of Sema3c staining was reduced in Rac1SHF compared to Rac1f/f
controls. (G) The level of Sema3c mRNA in Rac1SHF hearts at E13.5 was significantly
reduced compared to controls. *P<0.05 by unpaired Student’s t-test, n=4-5 hearts (E, F)
and 7-8 hearts (G) per group. FG, foregut; PC, pericardial cavity. Scale bars: 20 µm (A,
B), 10 µm (C, D).

3.4.7 Aortic valve defects in Rac1SHF hearts
Formation of valves involves a complex process of cushion formation, elongation,
valve remodelling and maturation.34 Both SHF progenitors and cardiac neural crest cells
contribute to aortic valve development. Neural crest cells are known to be involved in late
gestation remodelling and maturation of the aortic valves.7, 8 Thus, we predicted that the
decreased number of migrated cardiac neural crest cells into Rac1SHF hearts would also
affect development of Rac1SHFaortic valves. P0 Rac1SHF heart sections were analyzed and
found to have large, thickened aortic valve leaflets compared to controls which in
contrast had undergone remodeling and matured into thin, elongated leaflets (Fig. 3.8A,
B). Cell density of the aortic valve leaflets was also significantly decreased in P0 Rac1SHF
hearts compared to P0 Rac1f/f hearts (14.3 ± 1.0 vs. 17.8 ± 0.8 cells/1000 µm2, *P<0.05,
n=5-7), suggesting defects in ECM remodeling, which is necessary for the dense packing
of cells in the elongating valves.
To assess glycosaminoglycans (GAG), a component of ECM in the aortic valve,
toluidine blue staining was performed.35 The acellular space of the valve leaflets stained
light purple indicating the presence of GAG (Fig. 3.8C, D). Notably, a significantly
larger amount of GAG was present in Rac1SHF aortic valves compared to littermate
Rac1f/f controls at P0 (**P<0.01, Fig. 3.8G).
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During early stages of development there is little to no collagen present in the
semilunar valves. As the valves mature, collagen content increases, especially at the
commissure of the valves.36 Analysis of P0 Rac1f/f aortic valves after Masson’s trichrome
staining revealed early signs of maturation with collagen present at the valve commissure
(Fig. 3.8E). In comparison, P0 Rac1SHF aortic valves were less mature and had little to no
collagen present at the valve commissure (Fig. 3.8F).
Lineage tracing with mT/mG at E12.5 revealed decreased SHF progenitor
contribution to the OFT cushions in Rac1SHF hearts compared to control hearts which had
numerous SHF-derived GFP+ cells in the cushion mesenchyme (Fig. 3.9A, B, black
arrows). At E14.5, SHF contribution to the aortic valve leaflets continues to be severely
reduced in Rac1SHF hearts (Fig. 3.9C, D, black arrows). In addition, at both E12.5 and
E14.5, contribution of SHF progenitors to the Rac1SHF OFT myocardium seems to be
decreased compared to controls (Fig. 3.9A-D, red arrows). This lineage tracing data
strongly suggests an overall impairment in overall SHF progenitor cell contribution to the
developing heart in Rac1SHF embryos and a critical role for SHF Rac1 in maturation and
remodeling of the aortic valves.
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Figure 3.8. Aortic valve defects in Rac1SHF hearts.
Over 30% (9/28) of P0 Rac1SHF hearts exhibited thick aortic valve leaflets (B) compared
to the thin, remodeled valves of controls (A). Toluidine blue staining showed
glycosaminoglycans (GAG, light purple color) occupies the acellular space of Rac1SHF
and littermate valve leaflets (C and D). Masson’s trichrome staining in Rac1f/f aortic
valves showed collagen in the commissure of valve leaflets (E, arrows), which was
absent in Rac1SHF aortic valves (F, arrows). GAG positive area (light purple color) in
each valve leaflet (C and D) was quantified in G. **P<0.01 by unpaired Student’s t-test,
n=5-6 hearts per group. RCC, LCC and NCC are right, left and non-coronary cusps,
respectively. Scale bars: 100 µm (A-D), 10 µm (E, F).

Figure 3.9. Decreased SHF contribution to Rac1SHF OFT.
Fate mapping with mT/mG reporter shows a decreased SHF progenitor contribution to the
OFT myocardium (red arrows in B and D) in E12.5 and E14.5 Rac1SHF hearts compared
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to controls (red arrows in A and C). SHF contribution to the valve leaflets was also
severely reduced in Rac1SHF hearts compared to controls (black arrows, A-D). Paraffin
sections were immunostained with anti-GFP. Scale bars: 20 µm.

3.4.8 Abnormal aortic valve function in Rac1SHF hearts
The observed aortic valve defects would be predicted to result in functional impairment
of the valves. To assess the function of the malformed Rac1SHF aortic valves, intrauterine
echocardiography at E18.5 was performed. Embryos from timed pregnant females were
analyzed prior to genotyping and thus echo analysis was performed in a blinded manner.
All E18.5 Rac1f/f control embryos did not demonstrate any evidence of aortic valve
regurgitation (Fig. 3.10A). On the other hand, E18.5 Rac1SHF embryos were found to
have severe aortic regurgitation during diastole (Fig. 3.10B). In addition, left ventricular
internal diameter during systole (LVIDs) was significantly increased in Rac1SHF hearts
while no significant differences were observed in left ventricular internal diameter during
diastole (LVIDd). Both ejection fraction and fractional shortening in E18.5 Rac1SHF
embryos were also significantly reduced compared to controls (Table 3.2). Decreased left
ventricular function in Rac1SHF hearts is likely related to the defects in myocardial
development reported in our previous study.21 Overall, this echocardiography data further
defines a requirement for SHF Rac1 in development and functional maturation of the
aortic valves.
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Figure 3.10. Aortic valve regurgitation in Rac1SHF hearts.
Intrauterine pulsed-wave echocardiography at E18.5 showed that Rac1SHF hearts had
severe aortic regurgitation during diastole (B, red arrows), which is not observed in
Rac1f/f littermates (A). White arrows in A and B indicate forward blood flow during
systole. Shown are representatives of 5 fetuses per group from 4 mothers.
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Table 3.2. Intrauterine echocardiography in E18.5 Rac1SHF hearts.
Rac1f/f

Rac1SHF

(n=5)

(n=5)

Duration of backflow (ms)

0

198 ± 20

Velocity of backflow (mm/s)

0

256 ± 96

LVIDd (mm)

0.87 ± 0.03

0.89 ± 0.05

LVIDs (mm)

0.57 ± 0.02

0.66 ± 0.03 *

Ejection Fraction (%)

33.88 ± 1.15

25.64 ± 1.42 **

Fractional Shortening (%)

70.99 ± 1.49

58.71 ± 2.37 **

LVIDd, left ventricular internal diameter in diastole; LVIDs, left ventricular internal
diameter in systole. *P<0.05, **P<0.01 by unpaired Student’s t-test.

3.5 Discussion
Recent studies have established cell and tissue polarity as important regulators of cardiac
OFT development, especially factors involved in the PCP pathway.11,

12

However, the

role of Rac1 in cardiac OFT development is not clear. In the present study, we
demonstrated that a deficiency of Rac1 signaling in the anterior SHF disrupted progenitor
cell shape and overall epithelial organization in the splanchnic mesoderm. In addition, the
proliferation rate of SHF progenitors was decreased with a loss of Rac1 signaling.
Subsequently, as heart development progressed, these early defects in the SHF splanchnic
mesoderm resulted in a spectrum of OFT and aortic valve defects. We also showed that
Rac1 deficiency disrupted the levels of Sema3c, a chemoattractant for cardiac neural
crest cells, generated by the SHF-derived OFT myocardium, that would provide a
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mechanism for our observed reduction in migrating neural crest cells observed in the
developing OFT (Fig. 3.11).

Figure 3.11. Schematic diagram of mid-sagittal section of E9.5 splanchnic
mesoderm.
At E9.5, the Rac1f/f anterior SHF progenitors in the splanchnic mesoderm are organized
into a polarized epithelium (a). Chemotactic signals, such as Sema3c, secreted by the
OFT myocardium act as axonal guidance cues for migration of cardiac neural crest (NC)
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cells from the neural tube (A). In Rac1SHFembryos, the anterior SHF progenitors are
rounded and disorganized, displaying a loss of polarized epithelium characteristics (b).
Expression of chemotactic signals is reduced, resulting in decreased migration of neural
cells into the OFT (B).
Intricate signaling cascades exist between the cardiac neural crest and the SHF.
Defects in the cardiac neural crests can affect the SHF progenitors and vice versa.
Ablation of cardiac neural crest cells lead to a failure of the SHF progenitors to lengthen
the heart tube and to contribute to the OFT myocardium.30,

36

In addition to ablation,

tissue-specific genetic deletions in the cardiac neural crest cells, which affect signaling
pathways including Bmp, Smad and in the transcription factor Tbx3, all have secondary
effects on the SHF and result in defects to OFT remodeling, alignment and elongation.3739

Conversely, tissue-specific genetic deletions in the SHF tissue, including in Notch and

Tbx1, can also have a non-cell autonomous effect on migration of cardiac neural crest
cells into the developing heart.7, 40 Our study showed that conditional deletion of Rac1 in
the SHF reduced the migration of cardiac neural crest cells into the pharyngeal region,
supporting a role for Rac1 in supporting the intercellular signaling that exists between the
SHF and neural crest. The mechanism by which Rac1 signaling regulates expression of
the neural crest chemoattractant Sema3c in the SHF-derived OFT myocardium remains to
be determined. Studies have shown that Rac1 activates c-jun N-terminal kinase (JNK) to
increase gene expression, including expression of the zinc-finger transcription factor
Gata6.41,

42

Sema3c can be transcriptionally regulated by Gata6 and in humans, Gata6

mutations can cause PTA through disruptions in the semaphorin-plexin signaling
pathway.43, 44 Whether this Rac1-JNK-Gata6-Semaphorin signaling pathway is conserved
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in the SHF-derived OFT myocardium, and subsequently signals to the migrating cardiac
neural crest during cardiac morphogenesis remains to be determined in future studies.
The OFT defects observed in the Rac1SHF embryos in the present study are likely
due to a combination of abnormalities in several development events which are linked to
initial establishment of cell polarity, including proliferation and migration. Firstly,
proliferation of the Rac1SHF SHF progenitors in the splanchnic mesoderm is dramatically
reduced, thus decreasing the overall number of anterior SHF cells contributing to OFT
development. The two biological processes of cell polarity and proliferation are
coordinated during development, where the polarized state of a progenitor affects its
proliferation rate. This linkage has been clearly observed in development of the nervous
system.45, 46 In this study, we showed that a deficiency of Rac1 signaling in the anterior
SHF progenitors resulted in a loss of cellular organizationand is correlated with a
decrease in proliferation rate, further supporting a link between these two developmental
processes. Francou et al has also demonstrated a correlation with direct alteration of the
epithelial properties of the anterior SHF progenitors, resulting in reduced progenitor
proliferation rate and ectopic differentiation of the SHF progenitor cells.10 However, the
direct mechanistic link between proliferation and cell polarity in the SHF progenitors
remains unclear. In neural progenitors, apically localized aPKC attenuates the activity of
p27Xic1, which is an inhibitor of cyclin-dependent kinase-2 (Cdk2). This leads to
increased Cdk2 activity and shortening of the G1 and S phases, thus increasing the rate of
proliferation.47 Whether a similar mechanism exists in anterior SHF progenitors remains
to be determined. Furthermore, concomitant to a decrease in SHF progenitor cell
proliferation, a decreased migratory ability of the Rac1SHF anterior SHF progenitors to
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add to the arterial pole of the heart tube likely contributed to the observed OFT defects.
Establishment of cell polarity is intrinsically linked to migratory ability. Both polarization
and migration are events dependent on dynamic changes to the actin cytoskeleton, which
is regulated by Rac1.48 Evidence of impaired migratory ability of the Rac1SHF SHF during
heart development was recently demonstrated in our previous study.21 Migration defects
were also observed in the present study based on mT/mG lineage tracing, which showed
reduced contribution of SHF cells to the aortic valves and OFT, and impaired migration
of cardiomyocytes into the Rac1SHF proximal outlet septum during the myocardialization
process. Overall, these observations support establishment of SHF progenitor epithelial
organization as critical to the developmental process.
Valve remodeling and development is regulated by coordinated actions between
matrix metalloproteinase (MMPs) and a disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS) families of zinc metalloproteinases.49 Studies have
shown a role for Rac1 in the regulation of ECM degradation along with MMP expression
and activity.50, 51 The thickened Rac1SHF aortic valve leaflets along with decreased valve
cell density and increased deposition of glycosaminoglacans observed in this study
strongly suggest defects in valvular ECM degradation and remodeling. However, whether
Rac1 signaling in the SHF-derived cells residing in the aortic valve leaflets also regulate
the ECM through MMPs remains to be determined in future studies. Along with this,
blood flow-induced hemodynamics can influence valve morphogenetic cues.52 Our
previous study reported atrial and ventricular septal defects along with abnormalities in
development of the ventricles in Rac1SHF hearts.21 Whether these structural defects
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altered the hemodynamic flow and subsequently affected remodeling of the Rac1SHF
aortic valves remains to be determined.
In summary, our study is the first to show that Rac1 signaling in the anterior SHF
is critical to normal cell organization in the splanchnic mesoderm. Loss of Rac1 leads to
disruptions in anterior SHF progenitor cellular organization early in development and
impacts subsequent steps of heart development, including OFT and aortic valve
morphogenesis, along with signaling to the neural crest cells. Our study suggests that
perturbed Rac1 signaling in the anterior SHF could account for some of the OFT defects
observed in humans.

3.6 Footnotes
Supplemental Video Legends
Video S1. 3D reconstruction of OFT in E15.5 Rac1f/f heart. In Rac1f/f hearts, the aortic
arch (pink) is located on the left side, giving rise to the ascending and descending aorta
(red). The dorsal aorta runs parallel to the esophagus (yellow) and trachea (green).
Pulmonary artery is blue.
Video S2. 3D reconstruction of vascular ring in E15.5 Rac1SHF heart. In Rac1SHF hearts,
the aortic arch (pink) is located incorrectly on the right side, giving rise to the ascending
and descending aorta (red). The dorsal aorta wraps around the esophagus (yellow) and
trachea (green), forming a vascular ring. Pulmonary artery is blue.
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Chapter 4
4.1 Chapter Summary
Left ventricular noncompaction (LVNC) is a cardiomyopathy that can lead to
arrhythmias, embolic events and heart failure. Despite our current knowledge of cardiac
development, the mechanisms underlying noncompaction of the ventricular myocardium
are still poorly understood. The small GTPase Rac1 acts as a crucial regulator of
numerous developmental events; however, its role in ventricular myocardium
development is unclear. In the present study, we tested the hypothesis that Rac1 signaling
is critical for development of the ventricular compact myocardium. Using the ventricular
myocardium specific Nkx2.5-Cre transgenic mouse crossed to Rac1f/f, mice with a
ventricular myocardium specific deletion of Rac1 were generated (Rac1Nkx2.5). Embryonic
Rac1Nkx2.5 hearts at E13.5 - E18.5 were collected for histological analysis. Overall,
Rac1Nkx2.5 hearts displayed bifurcation of the ventricles, along with defective
trabeculation formation and a thin compact myocardium. Rac1Nkx2.5 hearts also exhibited
ventricular septal defects (VSDs) and double outlet right ventricle (DORV) or overriding
aorta. Cardiomyocytes in Rac1Nkx2.5 hearts were not polarized and expression of Scrib, a
PCP protein, was reduced. In addition, the proliferation rate of E9.5 Rac1Nkx2.5 ventricular
myocardium was reduced compared to controls. A Rac1 deficiency in the ventricular
myocardium

impairs

cardiomyocyte

polarization

and

ventricular

myocardium

organization, along with proliferative growth of the heart. A spectrum of CHDs arise in
Rac1Nkx2.5 hearts, implicating Rac1 signaling in the ventricular myocardium as a crucial
regulator of OFT alignment, along with trabecular and compact myocardium growth and
development.
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4.2 Introduction
Congenital heart defects (CHDs) are the most common human birth defect,
affecting up to 5% of live births.1,

2

The severity of these types of defects range from

simple defects with no symptoms at birth, such as a small atrial septal defect (ASD), to
complicated defects that are life-threatening and require intervention, such as Tetralogy
of Fallot (TOF).3-5 One particular defect known as left ventricular noncompaction
(LVNC) or “spongy myocardium” has no treatment at present, with the major therapy
being heart failure medications and anticoagulation medications.6 LVNC is classified as a
rare genetic cardiomyopathy, occurring in 0.01% to 0.27% of the population,
characterized by arrest of normal myocardium development, leading to a thin compact
myocardial layer and an extensive non-compacted trabecular network.7, 8 Noncompaction
of the ventricular myocardium can increase the risk of cardiac embolism, atrial
fibrillation, ventricular arrhythmia and heart failure.6,

8

Although this defect occurs

mostly in the LV, RV noncompaction has also been reported in less than one-half of
LVNC patients.9, 10
The ventricles grow and mature through a process of proliferation and
differentiation to form trabeculation and compact myocardium.11 In the mouse, trabecular
formation begins at approximately E9.5 where cardiomyocytes grow to form protrusions
of muscular ridges.12 The trabeculae then undergo a process of remodeling/compaction
where the bases of the trabeculation thicken and collapse into the myocardial wall.
Proliferation of the compact myocardium is concomitant with remodeling. By E14.5,
mature trabeculation is formed, along with a thick, compact myocardium.13, 14 Numerous
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signaling pathways have been implicated in development of the ventricular chambers
including Notch, BMP, FGF, retinoic acid and PCP signaling.11, 15 In addition, various
mouse models of ventricular noncompaction defect have been generated but the
ventricular defects between the mouse models are not consistent, reflecting the complex
process of ventricular myocardium development. To date, the complete signaling
mechanisms underlying ventricular myocardium development are still not completely
understood. 16, 17
The small GTPase, Rac1, acts as a crucial regulator of numerous developmental
events including proliferation, cell cycle progression, cell survival, differentiation and
regulation of cell shape, morphology and polarity.18 Specifically, the importance of Rac1
signaling in embryonic heart development has emerged in recent studies19, 20 Our work
has demonstrated a critical role for Rac1 signaling in the anterior SHF and anterior-SHF
derived structures including the RV, interventricular septum and the OFT. Rac1 regulates
cardiomyocyte polarization in the RV and formation of the cardiac apex.19 However, the
role of Rac1 in development of the LV myocardium is unclear. In order to study the role
of Rac1 in the ventricular myocardium, we generated a ventricular myocardium specific
deletion of Rac1 using the Nkx2.5-Cre transgenic mouse, which has Cre recombinase
activity in both the RV and LV.21 We show that Rac1 signaling is crucial for ventricular
myocardium development and downregulation of Rac1 leads to a spectrum of CHDs
including thin compact myocardium and defective trabeculation development, similar to
the features of LVNC. Rac1 deficient hearts also had a bifid cardiac apex and OFT
alignment defects. Furthermore, we showed that a Rac1 deficiency in the ventricular
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myocardium disrupts proliferation along with the organization and polarization of
cardiomyocytes.

4.3 Methods
4.3.1 Mice
The Rac1f/f C57BL/6 mouse line (Stock #5550) and mT/mG C57BL/6 mouse line (Stock
#7676) were purchased from Jackson Laboratory, Bar Harbor, Maine

22, 23

. The Nkx2.5-

Cre C57BL/6 transgenic mouse was a generous gift from Dr. Chi-Chung Hui at SickKids
Hospital, University of Toronto, originally generated by McFadden et al.21 The mT/mG
mouse is a global double-fluorescent Cre reporter mouse. This reporter mouse expresses
membrane-targeted Tomato (mT) before Cre-excision and membrane-targeted GFP (mG)
after excision of mT.23 A breeding program to generate Nkx2.5-Cre;Rac1f/f (Rac1Nkx2.5)
and Nkx2.5-Cre;mT/mG mice was carried out and genotyping was performed as
described previously.19 Genotyping primer sequences are listed in Table 4.1. Mouse
experiments and procedures were approved by the Animal Use Subcommittee at the
University of Western Ontario in accordance with the guidelines of the Canadian Council
of Animal Care.
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Table 4.1. Genotyping PCR primer sequences.
Gene

Forward

Reverse

Nkx2.5-Cre

tgccacgaccaagtgacagc

ccaggttacggatatagttcatg

Rac1f/f

tccaatctgtgctgcccatc

gatgcttctaggggtgagcc

mTmG

ctctgctgcctcctggcttct

cgaggcggatcacaagcaata
Mutant reverse:
tcaatgggcgggggtcgtt

4.3.2 Histological Analysis
Embryonic samples (thoracic cavity) were fixed overnight in 4% paraformaldehyde at
4°C, dehydrated and paraffin embedded. Samples were serially sectioned at 5 µm from
the top of the aortic arch to the apex of the heart with a Leica RM2255 microtome.
Sections were mounted onto positively charged albumin/glycerin coated microslides.
Slides were stained with hematoxylin and eosin (H/E) for histological analysis and
images were captured using a light microscope (Observer D1, Zeiss, Germany).

4.3.3 Immunohistochemistry
Immunohistochemical staining was performed on paraffin heart sections. Antigen
retrieval was carried out in sodium citrate buffer (pH 6.0) at 92 °C using a BP-111
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laboratory microwave (Microwave Research & Applications, Carol Stream, Illinois).
Immunostaining was performed with primary antibodies for GFP (Abcam) and Scrib
(Santa Cruz) followed by incubation with biotinylated secondary antibody and avidin and
biotinylated HPR (Santa Cruz). Diaminobenzidine (DAB) substrate solution was used to
visualize the substrate and slides were counterstained with hematoxylin. Images were
captured with Zeiss Observer D1 microscope using AxioVision Rel 4.7 software. For
proliferation and apoptosis analysis, E9.5 heart samples were fixed in 4%
paraformaldehyde for one hour, cryoprotected in 30% sucrose and embedded in FSC22
frozen section media (Leica). Samples were sectioned in a sagittal orientation with a
Leica cryostat at 10 µm thick onto glass slides. Slides were incubated with
phosphohistone-H3 (phospho S10) (Abcam), cleaved caspase-3 (Cell Signaling) primary
antibody, Alexa Fluor 647 wheat germ agglutinin (Invitrogen), Alexa Fluor 488
phalloidin (Life Technologies) and counterstained with Hoechst 33342 (Invitrogen).
Confocal images were obtained at the Biotron Research Centre, Western University with
a Zeiss LSM 510 Duo microscope using ZEN 2012 software (Zeiss, Germany).

4.3.4 Quantitative Real Time RT-PCR
Total RNA was isolated from E12.5 ventricular myocardium using the RNeasy Mini Kit
(QIAGEN). Reverse transcription reaction was performed, as described previously.19
Briefly, M-MLV Reverse Transcriptase (Invitrogen) and EvaGreen qPCR Mastermix
(Applied Biological Materials Inc.) was used for real time thermal cycling. 28S rRNA
was used as an internal control. The Eppendorf Mastercycler Realplex Real-Time PCR
machine was used and samples were amplified for 35 cycles. The mRNA level of Rac1 in
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relation to 28S rRNA was determined using a comparative CT method.24 Real time RTPCR primer sequences are listed in Table 4.2.
Table 4.2. Real time RT-PCR primer sequences.
Gene

Forward

Reverse

Rac1

aacctgcctgctcatcagtt

ttgtccagctgtgtcccata

28S

ttgaaaatccgggggagag

acattgttccaacatgccag

4.3.5 Western Blot Analysis
Rac1 protein expression from E12.5 ventricular myocardium was measured by western
blot analysis. Briefly, 25 µg of protein from isolated ventricular tissue was separated by
12% SDS-Page gel and transferred to nitrocellulose membranes. Blots were probed with
antibodies against Rac1 (1:500, Santa Cruz) and α-actinin (1:5000, Sigma). Blots were
then washed and probed with horseradish peroxidase conjugated secondary antibodies
(1:2500, Bio-Rad) and detected using an ECL detection method. Densitometry was then
performed to quantify the signal.

4.3.6 Statistical Analysis
Data are presented as means ± SEM. An unpaired Student’s t test was employed to test
for significance when data passed a normality test. Differences were considered
significant at P<0.05.
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4.4 Results
4.4.1 Generation of a transgenic mouse with a Rac1 deficiency in the
ventricular myocardium
Nkx2.5-Cre transgenic mice and Rac1f/f mice were crossed to generate Nkx2.5Cre;Rac1f/f (Rac1Nkx2.5) offspring. The Cre recombinase in the Nkx2.5-Cre mouse line is
activated after E8.5 and initial specification of cardiac progenitors.21 To confirm a
knockdown in Rac1 mRNA expression, E12.5 Rac1Nkx2.5 ventricles were isolated for
RNA and real-time PCR was performed. Rac1 mRNA expression was significantly
decreased by approximately 35% in E12.5 Rac1Nkx2.5 ventricular myocardium compared
to littermate Rac1f/f controls (Fig. 4.1A). Protein from E12.5 Rac1Nkx2.5 ventricular
myocardium was also isolated for western blot analysis. The ratio of Rac1 protein
expression to α-actinin was reduced by 42% in E12.5 Rac1Nkx2.5 ventricular myocardium
compared to littermate Rac1f/f controls (Fig. 4.1B). These results confirm that Nkx2.5-Cre
mediated recombination sufficiently downregulates Rac1 expression in the ventricular
myocardium of the developing embryonic heart.
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Figure 4.1.

Generation of mouse line with a ventricular myocardium specific

deletion of Rac1 (Rac1Nkx2.5).
Nkx2.5-Cre transgenic mice were crossed to Rac1f/f to generate Rac1Nkx2.5 mice. Rac1
mRNA expression was significantly reduced in E12.5 Rac1Nkx2.5 ventricular myocardium
compared to Rac1f/f littermates (A). Western blot analysis of E12.5 ventricular
myocardium showed a significant decrease in Rac1 protein in Rac1Nkx2.5 hearts compared
to controls (B). *P<0.05 by Student’s t-test.

4.4.2 Lineage tracing of Nkx2.5-Cre transgenic mouse
To trace where the Cre recombinase is active in Nkx2.5-Cre transgenic hearts,
Nkx2.5-Cre mice were crossed to mT/mG reporter mice, which marks all tissues
possessing Cre recombinase activity with GFP. McFadden et al, the group who first
created the Nkx2.5-Cre transgenic mouse, used a lacZ reporter to show that the Cre
recombinase is active throughout the ventricular myocardium with minimal
recombination in the OFT and atria.21 At E12.5, we showed with the Nkx2.5-Cre;mT/mG
mouse that the Cre recombinase is active throughout the ventricular myocardium and a
large portion of the atria (Fig. 4.2A). In addition, a majority of the pulmonary artery
myocardium and only some cells in the aorta, were GFP+ in E12.5 Nkx2.5-Cre;mT/mG
hearts (Fig. 4.2B). Closer analysis of the aortic valves showed that some of the cells in
the early aortic valves were also GFP+ in the Nkx2.5-Cre;mT/mG hearts (Fig. 4.2C).
Furthermore, closer analysis of the epicardium and endocardial cells at E18.5 showed that
these cells remained RFP+, indicating no Cre recombinase activity in these cell types
(Fig. 4.2D-F). Thus, the Nkx2.5-Cre mouse is an effective transgenic mouse to use to
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study development of the ventricular myocardium, as the majority of these cells are
GFP+.

Figure 4.2. Lineage tracing with Nkx2.5-Cre;mT/mG mice.
GFP immunostaining of E12.5 Nkx2.5-Cre;mT/mG paraffin heart sections showing Cre
recombinase activity in the ventricular myocardium (A), OFT (B) and aortic valve
leaflets (C). Cryosections of E18.5 Nkx2.5-Cre;mT/mG hearts showed that the
epicardium (arrows) and endothelial cells (arrowhead) remain RFP+ in Nkx2.5Cre;mT/mG hearts (D-F). RV, right ventricle; LV, left ventricle; PA, pulmonary artery;
Ao, aorta; epi, epicardium. Scale bars: 250 µm (A-C), 10 µm (D-F).

4.4.3 Congenital heart defects in Rac1Nkx2.5 hearts
All P0 Rac1Nkx2.5 offspring were found dead at birth (n=5) from two litters. Gross
morphological analysis of these P0 Rac1Nkx2.5 hearts revealed a bifid cardiac apex, similar
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to what was observed and reported in our previous study with a Mef2c-Cre anterior
second heart field-specific deletion of Rac1.19 Examination of all Rac1Nkx2.5 hearts at
earlier embryonic time points showed evidence of a bifid cardiac apex as well, along with
enlarged atria (Fig. 4.3A). In addition, Rac1Nkx2.5 hearts had incomplete development of
the interventricular septum, resulting in a ventricular septal defect (VSD) (Fig. 4.3B-C,
Table 4.3). Alignment of the outflow tract (OFT) to the ventricles was also defective in
Rac1Nkx2.5 hearts compared to littermate Rac1f/f controls. A double outlet right ventricle
(DORV) was observed in 11 of the 17 Rac1Nkx2.5 hearts (Fig. 4.3D-G, Table 4.3) and 6 of
the 17 Rac1Nkx2.5 hearts exhibited an overriding aorta (Table 4.3). In addition, both the
left ventricle (LV) and right ventricle (RV) of Rac1Nkx2.5 hearts had defective
trabeculation (Fig. 4.4A-D). The compact myocardium of both Rac1Nkx2.5 ventricles at
E15.5 was poorly formed and significantly thinner compared to littermate Rac1f/f controls
(Fig. 4.4E). These findings suggest a critical role for Rac1 in interventricular septum
formation, OFT alignment and development of the trabecular and compact ventricular
myocardium.
Table 4.3. Congenital heart defects in Rac1Nkx2.5 hearts (E14.5 – P0).
Bifid
apex

VSD

DORV

Overriding
aorta

Thin
myocardium

N=17

17

17

11

6

17

%

100

100

64.7

35.3

100
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VSD, ventricular septal defect; DORV, double outlet right ventricle. All 17 Rac1SHF
hearts had more than one type of CHD. No CHDs defects were found in littermate E14.5P0 Rac1f/f hearts (n=11).
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Figure 4.3. Congenital heart defects in Rac1Nkx2.5.
Bifid cardiac apex in an E16.5 Rac1Nkx2.5 heart. Arrow indicates bifurcation between the
RV and LV (A). Ventricular septal defect (arrowhead) was found in E15.5 Rac1Nkx2.5
hearts. Arrow indicates bifid cardiac apex (B, C). Double outlet right ventricle (DORV)
was found in E15.5 Rac1Nkx2.5 hearts. The pulmonary artery connects to the RV in both
Rac1f/f controls and Rac1Nkx2.5 hearts (D, E). The Rac1Nkx2.5 aorta (G) incorrectly connects
to the RV compared to Rac1f/f controls, where the aorta connects to the LV (F). RA, right
atrium; LA, left atrium. Scale bars: 500 µm.
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Figure 4.4. Ventricular myocardium defects in Rac1Nkx2.5 hearts.
The RV and LV myocardium and trabeculation of E15.5 Rac1Nkx2.5 hearts (B, D) were
severely defective compared to Rac1f/f controls (A, C). The thickness of the compact
myocardial wall in E15.5 Rac1Nkx2.5 RV and LV was significantly decreased compared to
littermate controls (E). Double-headed arrows in A-D indicate measurements of wall
thickness. ***P<0.001 by Student’s t-test. Scale bars: 100 µm.

4.4.4 Loss of cell polarity and organization in Rac1Nkx2.5 hearts
To analyze the organization of the cardiomyocytes in the ventricular myocardium,
E18.5 Rac1Nkx2.5 heart sections were stained with wheat germ agglutinin (WGA), which
marks cell borders, and phalloidin to mark F-actin filaments. WGA staining revealed
rounded, spherically shaped cardiomyocytes in Rac1Nkx2.5 hearts, in both the RV and LV
(Fig. 4.5B). In comparison, littermate ventricular myocardium had cardiomyocytes that
had undergone polarization and were an elongated shape in both the RV and LV (Fig.
4.5A). In addition, Rac1Nkx2.5 hearts had severely disrupted F-actin filament organization
(Fig. 4.5D) compared to controls, which had long, parallel running F-actin filaments
throughout the myocardium (Fig. 4.5C). These findings are similar to the observations
from our first study, where Rac1 was deleted in the SHF and all SHF-progenitors in
Rac1SHF hearts.19 The RV in the SHF-Rac1 deficient hearts showed similar myocardial
disorganization as the ventricular myocardium of Rac1Nkx2.5 hearts in this study. This data
suggests a crucial role for Rac1 in the organization, polarization and elongation of
cardiomyocytes during embryonic heart development.
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Figure 4.5. Disruption of cardiomyocyte polarity and organization in Rac1Nkx2.5
hearts.
WGA staining in E18.5 cryosections show rounded cardiomyocytes in Rac1Nkx2.5
ventricular myocardium (B) compared to the elongated cardiomyocytes in controls (A).
F-actin filament organization is disrupted in Rac1Nkx2.5 myocardium (D) compared to
controls (C). Scale bars: 10 µm.

4.4.5 Decreased Scrib protein in Rac1Nkx2.5 hearts
Scrib genetically interacts with Rac1 and Scrib protein forms a complex with the
Rac1-GEF, β-PIX, and Rac1 in the developing myocardium. Loss of either Scrib or Rac1
leads to a reduction in membrane association of the other.20 To analyze the expression of
Scrib, immunostaining was performed on E15.5 Rac1Nkx2.5 hearts. Scrib is highly
expressed in the myocardium surrounding the opening of the aorta in control E15.5 hearts
(Fig. 4.6A). In comparison, the expression of Scrib in this area is reduced in E15.5
Rac1Nkx2.5 heart sections (Fig. 4.6B). In addition, expression of Scrib was also reduced in
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E15.5 Rac1Nkx2.5 RV and LV myocardium compared to littermate controls (Fig. 4.6C-F).
Similar to what was described in our first study,19 Scrib protein expression is abundant in
the interventricular junction in control hearts at E15.5. Overall, Scrib protein expression
was significantly decreased in E15.5 Rac1Nkx2.5 hearts compared to littermate controls
(Fig. 4.6G). The loss of Scrib expression in Rac1Nkx2.5 hearts suggests a disruption in
polarity and the PCP pathway, further supporting a failure of cardiomyocytes to undergo
polarization.
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Figure 4.6. Loss of Scrib expression in Rac1Nkx2.5 hearts.
Scrib immunostaining was performed on E15.5 Rac1Nkx2.5 and Rac1f/f heart sections. The
areas analyzed included the myocardium surrounding the aorta (A, B), RV (C, D) and the
LV (E, F). The number of Scrib-expressing positive cells was significantly decreased in
the myocardium surrounding the aorta (OFT), RV and LV of Rac1Nkx2.5 hearts (G).
*P<0.05, **P<0.01 by Student’s t-test. Scale bars: 50 µm.

4.4.6 Decreased proliferation rate in Rac1Nkx2.5 hearts
The observed defects in Rac1Nkx2.5 ventricular myocardium development could
also be attributed to a decrease in cell proliferation and/or aberrant apoptosis.
Proliferation of the heart chambers has been shown to be highest at E9.5 in the
developing mouse heart.25 Thus, proliferation of E9.5 Rac1Nkx2.5 hearts was analyzed by
immunostaining for phospho-histone H3 (pHH3), which is a marker of the mitotic phase
of cell division. The proliferation rate of the ventricular chambers was found to be
significantly reduced in E9.5 Rac1Nkx2.5 hearts compared to littermate Rac1f/f controls
(Fig. 4.7A-C). Along with this, cyclin D1, a marker of cell cycle progression through the
G1/S phase, was significantly decreased in E9.5 Rac1Nkx2.5 myocardium compared to
Rac1f/f controls (Fig. 4.7D-F). Immunostaining for cleaved caspase-3 (CC3), a marker of
activated apoptosis, showed little to no apoptosis in both control E9.5 Rac1f/f and
Rac1Nkx2.5 ventricular myocardium (Fig. 4.7G, H), while apoptotic cells were found in
tissue outside of the myocardium (Fig. 4.7I, J). However, this data does not preclude
apoptosis from potentially playing a role in later developmental time points in Rac1Nkx2.5
hearts. Thus, the decreased proliferation rate and expression of cyclin D1 in Rac1Nkx2.5
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hearts suggests a critical role for Rac1 in regulation of cardiomyocyte proliferation and
cell cycle progression in the ventricular myocardium, after initial specification of cardiac
progenitors.
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Figure 4.7. Decreased proliferation rate in Rac1Nkx2.5 hearts.
Phospho-histone H3 (pHH3) immunostaining to mark proliferating cells undergoing
mitosis in ventricular myocardium of E9.5 Rac1Nkx2.5 and Rac1f/f hearts (A, B).
Proliferation rate was significantly decreased in E9.5 Rac1Nkx2.5 ventricular myocardium
compared to littermate controls (C). *P<0.05 by Student’s t-test. Cyclin D1
immunostaining to mark cell cycle progression in ventricular myocardium of E9.5
Rac1Nkx2.5 and Rac1f/f hearts (D, E). Cyclin D1 was significantly decreased in E9.5
Rac1Nkx2.5 ventricular myocardium compared to littermate controls (F). **P<0.01 by
Student’s t-test. Cleaved caspase-3 (CC3) immunostaining to mark apoptotic cells in
ventricular myocardium of E9.5 Rac1Nkx2.5 and Rac1f/f hearts. No apoptosis was detected
in E9.5 Rac1Nkx2.5 and Rac1f/f ventricular myocardium (G, H). Apoptotic cells were
detected elsewhere in the embryo in cells outside of the ventricular myocardium (I, J).
Scale bars: 10 µm (A, B, H, I), 50 µm (D-G).

4.5 Discussion
Recent studies have implicated PCP signaling and cell polarity as a critical
regulator of compact myocardium development. Vangl2, Scrib and Dishevelled mouse
mutants have cardiomyocytes that are not polarized and the ventricular myocardium is
thinned, resembling LVNC.26-29 Rac1 is a known downstream effector of PCP signaling;
however the role of Rac1 in ventricular myocardium development is unclear.30 In the
present study, we demonstrated that downregulation of Rac1 signaling in the ventricular
myocardium disrupted formation of a trabecular network and development of the
compact myocardium. In addition, Rac1Nkx2.5 mice had a bifid cardiac apex, defects in
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ventricular septum formation and OFT alignment. The organization and polarization of
cardiomyocytes in the Rac1deficient ventricular myocardium was also abnormal. Overall,
proliferation was decreased in Rac1Nkx2.5 hearts, along with expression of the PCP
protein, Scrib. Our study demonstrates a critical role for Rac1 signaling during
ventricular trabeculation and compact myocardium development (Fig. 4.8).
Proliferation of the heart is a regulated spatially and temporally during
development. Proliferation rate of the ventricular chambers peak at E9.5 and will
gradually decrease during development.25 Studies have shown that cardiomyocyte
proliferation during development is the major determinant of overall cardiac size. The
mass of the heart must increase to match the increasing circulatory demands of the
growing embryo.31 Rac1 has been shown to regulate proliferation through various
pathways. Our data showed that a Rac1 deficiency in the ventricular myocardium led to a
reduced proliferation rate. However, the mechanism through which Rac1 regulates
cardiomyocyte proliferation is unclear. Rac1 has been shown to regulate cyclin D1, a cell
cycle regulator, through NF-κB.32,

33

Whether Rac1 signaling acts through the NF-κB

pathway in the developing ventricular myocardium to regulate cell cycle progression and
proliferation should be determined in future studies (Fig. 4.8).
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Figure 4.8. Rac1 regulation of ventricular myocardium development.
Rac1 signaling regulates actin polymerization, leading to cardiomyocyte polarization. In
addition, Rac1 regulates cardiomyocyte proliferation through cyclin D1. Overall, Rac1
signaling regulates proliferation and polarity of cardiomyocytes, leading to development
of the compact myocardium and trabeculation formation.
An earlier report by Boczonadi et al also used a Nkx2.5-Cre;Rac1f/f mouse line in
their studies.20 However, the Nkx2.5-Cre mouse used by Boczonadi et al was an Nkx2.5
heterozygous mouse since the Cre recombinase gene was knocked into the Nkx2.5
genetic locus.34 In contrast, the Nkx2.5-Cre mouse used in this study is a transgenic
mouse and retains homozygous expression of Nkx2.5.21 The Nkx2.5-Cre;Rac1f/f mice used
in Boczonadi et al were embryonic lethal by E13.5, which precluded analysis of
ventricular septation and OFT alignment with the developing ventricles.20 The earlier
lethality of the Nkx2.5-Cre;Rac1f/f mouse line compared to the Rac1Nkx2.5 used in this
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study is likely due to the heterozygous expression of Nkx2.5 compounded with decreased
Rac1 signaling in the ventricular myocardium. Furthermore, whether the CHDs reported
in the study by Boczonadi et al are exclusively due to deficient Rac1 signaling or also due
to downregulation of Nkx2.5 is unclear. Our data only implicates Rac1 signaling and we
were able to demonstrate that Rac1Nkx2.5 hearts also exhibit VSDs and OFT alignment
defects.
Our previous work also reported a bifid cardiac apex when Rac1 was specifically
deleted in the anterior SHF and all anterior SHF-derived cells.19 We had postulated that
loss of Rac1 signaling in the RV led to an inability of the nonpolarized and disorganized
cardiomyocytes to bridge the interventricular junction to unify the two developing
ventricles and form a distinct cardiac apex. However, from this work using the Rac1Nkx2.5
hearts, we show that development of the cardiac apex is also dependent on polarization
and organization of the cardiomyocytes in the LV myocardium. Interestingly, other
reports where PCP signaling was disrupted did not report observations of a bifid cardiac
apex, despite similar reports of cardiomyocyte disorganization.27,

28

Rac1 is a known

downstream effector of PCP signaling, regulating actin cytoskeleton dynamics and cell
polarity.35, 36 Our findings suggests that development of a bifid cardiac apex involves a
pathway specific to Rac1 signaling. In addition, since Rac1 is a pleiotropic effector of
numerous cellular events, the concomitant disruption of several cellular mechanisms are
likely responsible for bifid cardiac apex, along with the other observed CHDs in
Rac1Nkx2.5 hearts.
Our lineage tracing analysis with the mT/mG global double florescence mouse
showed similar GFP+ expression in domains of the heart that were reported by McFadden
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et al, who used a lacZ reporter. However, we also showed Cre recombinase activity in the
OFT and atria, which were reported to be minimal by McFadden et al.21 This discrepancy
in Cre recombinase activity may be due to the additional β-galactosidase enzymatic
reaction step that is required to visualize the blue colour of lacZ staining, making it a less
efficient reporter compared to a GFP reporter. These results suggest that future lineage
tracing analysis should use a florescence reporter as a more reliable readout of expression
compared to a lacZ reporter.
Rac1 is involved in reactive oxygen species (ROS) generation through activation
of NADPH oxidase.37,

38

ROS mediates numerous cellular functions including

proliferation, cell survival, differentiation and migration.39 The levels of ROS are finely
tuned in a cell to regulate these diverse functions. For example, excess ROS induces
apoptosis while basal levels of ROS regulate gene expression and proliferation.40-42 Work
in our lab has shown that ROS levels must be tightly regulated to facilitate normal
cardiac development. Excess ROS induced by pregestational maternal diabetes and
decreased levels of ROS in the NADPH oxidase Nox2 knockout mouse have a
detrimental effect on heart development, leading to a spectrum of CHDs.43, 44 Whether the
CHDs observed in the Rac1Nkx2.5 hearts can also be attributed to decreased ROS levels
should be determined in future studies.
In summary, our study suggests a critical role for Rac1 regulation of
cardiomyocyte organization and polarization in development of the ventricular
myocardium. A Rac1 deficiency in the myocardium disrupts cardiomyocyte organization
and proliferation, leading to bifid cardiac apex, VSDs and OFT alignment and ventricular
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myocardium defects. Whether perturbed Rac1 signaling in the ventricular myocardium
underlies human cases of LVNC should be further studied.
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5

Chapter 5 Discussion

5.1 Summary of Major Findings
The overall objective of this thesis was to investigate the role of Rac1 during
embryonic heart development in mice. Specifically, I studied the role of Rac1 in
cardiomyocyte polarity and development of OFT, cardiac septum and the ventricular
myocardium. To carry out these experiments, the Cre/LoxP system was used throughout
the studies to generate a mouse model of Rac1 deficiency. More specifically, the Rac1f/f
transgenic mouse was used, combined with the anterior SHF-specific Mef2c-Cre or the
ventricular myocardium specific Nkx2.5-Cre transgenic mouse. The major aim of this
thesis was to unravel the mechanisms of Rac1 regulation of cell polarity during
embryonic heart development. Experimental approaches included in vivo lineage tracing,
histological analysis of heart sections, immunostaining, in vitro cell cultures, ex vivo
heart explants, and biochemical and molecular assays.
In Chapter 2, I investigated the role of Rac1 in cardiomyocyte polarity and
development of cardiac septium and right ventricular myocardium. To carry out this aim,
the anterior SHF-specific Mef2c-Cre mouse was bred to the Rac1f/f mouse to generate a
SHF-specific deletion of Rac1, Rac1SHF. One of the distinct CHDs first noticed was a
bifid cardiac apex in Rac1SHF hearts, where the RV bifurcates from the LV instead of
forming a distinct left-pointing apex. Cases of bifid cardiac apex are extremely rare in
humans and are often associated with other CHDs.1, 2 Whether cases of bifid cardiac apex
in humans are also associated with abberant Rac1 signaling during embryonic
development remains unknown. The Rac1SHF hearts also had other CHDs including
VSDs, ASDs and defective myocardium and trabeculation formation in the RV. Further
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analysis of heart cryosections showed that cardiomyocyte organization, polarity and
alignment was severly disrupted in P0 Rac1SHF hearts. The Rac1SHF cardiomyocytes were
rounded and spherical shaped compared to controls, which were elongated and aligned
with each other. The actin cytoskeleton organization, expression of β-catenin cell-cell
junctions and expression of the PCP protein, Scrib, were also disrupted in Rac1SHF hearts.
In addition, explant cultures of E12.5 Rac1SHF;mT/mG RV showed defects in migratory
ability of GFP+ SHF-derived cells. In vitro primary cardiomyocyte cultures from Rac1SHF
hearts displayed defects in lamellipodia formation and cardiomyocyte polarization along
with a decreased cardiomyocyte axis length. Furthermore, in vivo lineage tracing showed
a deficient SHF progenitor contribution to Rac1SHF hearts, likely due to defects in
migratory ability of SHF progenitors. Molecular analysis demonstrated decreased
expression levels of key cardiac transcription factors in E12.5 Rac1SHF RV compared to
littermate controls including Nkx2.5, Gata4, Tbx5 and Hand2. In addition, apoptosis was
significantly upregulated in the RV and interventricular septum of E11.5 Rac1SHF hearts
with no significant difference in proliferation rate compared to littermate controls.
Overall, this study showed that Rac1 is critical to embryonic heart development by
regulating the actin cytoskeleton to direct cardiomyocyte polarity and migration of SHF
progenitors into the developing heart.
Building upon the findings that Rac1 is crucial for cardiomyocyte polarity from
the first study in Chapter 2, the experiments in Chapter 3 analyzed the role of Rac1 in
OFT development, which is known to be a process regulated by cell polarity.3,

4

This

study demonstrated for the first time that Rac1 is critical for overall organization of the
anterior SHF progenitors and OFT development. Analysis of Rac1SHF embryos at E9.5
showed less SHF cells in the splanchnic mesoderm and the proliferation rate of SHF cells
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was significantly reduced compared to controls. The Rac1

SHF

SHF progenitors in the

dorsal pericardial wall had defects in overall cell shape and cell organization compared to
littermate controls. As a result of these early defects at E9.5, the Rac1SHF OFT was
shortened and organization of the myocardial cells was disrupted by E10.5. Furthermore,
Rac1SHF hearts displayed a spectrum of OFT defects including double outlet right
ventricle (DORV), overriding aorta, persistent truncus arteriosus (PTA), transposition of
the great arteries (TGA), aortic atresia, pulmonary stenosis, vascular rings and aortic
valve defects. At E12.5, Rac1SHF myocardial cells lacked a polarized morphology and
displayed abnormalities in myocardialization and migration of cardiomyocytes into the
flanking OFT cushion. Subsequently, the P0 Rac1SHF proximal OFT remained
mesenchymal instead of muscularized. Interactions between SHF progenitors and cardiac
neural crest cells have been shown to be critical for remodeling and development of the
aortic arches.5 Sema3c expression, which acts as a chemoattractant for neural crest cells,6
was reduced in E10.5 Rac1SHF OFT myocardium. Consequently, the number of migrating
cardiac neural crest cells into Rac1SHF hearts was reduced. Moreover, in vivo lineage
tracing with the mT/mG reporter mouse showed a decreased contribution of SHF cells to
the Rac1SHF OFT myocardium and aortic valves at E12.5 and E14.5. Lastly, intrauterine
echocardiography performed at E18.5 demonstrated evidence of aortic valve
regurgitation along with reduced ejection fraction and fractional shortening in Rac1SHF
embryos. Taken together, this data suggests that Rac1 regulates SHF progenitor cell
shape and organization in the splanchnic mesoderm, which is critical for overall cardiac
OFT development.
In Chapter 4, the Nkx2.5-Cre transgenic mouse was used to study the role of
Rac1 in development of the ventricular myocardium. Thus far, in Chapter 2 and Chapter
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3 of this thesis, the Mef2-Cre mouse was used, which directs Cre recombinase activity
starting at E7.5 to the anterior SHF and all anterior SHF-derived structures, including the
RV, interventricular septum and OFT.7 The Cre recombinase in the Nkx2.5-Cre
transgenic mouse is activated after initial specification of cardiac progenitors at E8.5 but
not in earlier cardiac progenitors and is also active in the developing LV, along with the
RV myocardium.8 Mice with a Rac1 deficiency in the ventricular myocardium,
Rac1Nkx2.5, also had bifid cardiac apex, similar to what was observed in Chapter 2 with the
Rac1SHF hearts. Other CHDs found in Rac1Nkx2.5 hearts included VSDs, defects in
trabeculation formation and a significantly thinner compact myocardium. Rac1Nkx2.5
hearts also had misalignments of the OFT with the ventricles, leading to DORV and
overriding aorta. Actin filament formation was severly disrupted and cardiomyocytes
failed to undergo polarization in Rac1Nkx2.5 hearts. Proliferation of the myocardium in
E9.5 Rac1Nkx2.5 hearts was significantly reduced compared to littermate controls, while no
significant apoptosis was observed at this time point. In addition, expression of the PCP
protein, Scrib, was reduced in E15.5 Rac1Nkx2.5 hearts compared to littermate controls.
Overall, our study suggests a critical role for Rac1 regulation of myocardial organization
and polarization. Whether perturbed Rac1 signaling in the ventricular myocardium is
related to cases of left ventricular noncompaction (LVNC) defects reported in human
patients remains to be determined.
In summary, I have demonstrated a crucial role for Rac1 in embryonic heart
development. More specifically, I showed that Rac1 is critical for development of
cardiomyocyte polarity and a deficiency in Rac1 leads to defects in cardiomyocyte
polarization. Next, I showed that Rac1 is crucial for organization of the anterior SHF
progenitors in the dorsal pericardial wall and overall OFT development. Lastly, I showed
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that Rac1 is essential for ventricular myocardium development and a Rac1 deficiency
leads to trabecular defects and noncompaction of the myocardium. My studies provide
novel insights into the developmental mechanisms that may be disturbed in some cases of
human CHDs and may provide information for improved diagostics and therapies. A
summary of the findings from these studies is shown in Figure 5.1.

Figure 5.1.

Summary of the cellular mechanisms by which Rac1 regulates

embryonic heart development.
Rac1 signaling regulates various mechanisms of heart development including
proliferation, actin polymerization, gene expression and cell survival, leading to
cardiomyocyte polarity, development of the OFT, cardiac septum and the ventricular
myocardium.

189

5.2 Study Limitations
5.2.1 Mouse models of CHDs
Mouse models have been used extensively to understand physiology and
pathophysiology, including the mechanisms of normal heart development and how CHDs
arise in humans. The cardiac developmental events and anatomy of the heart are very
similar in mouse and humans.9 Since the mouse genome was first sequenced in 2002, it
has been shown that approximately 99% of mouse genes are homologous to human
genes.10 This makes the mouse an excellent mammalian model for comparative genomics
and a powerful tool to help us further understand cardiogenesis. In addition,
manipulations to the mouse genome are relatively straightforward and specific, making it
an invaluable model to study the mechanisms of CHDs.11 However, despite great
advancements to research that the genetically modified mouse has provided, use of the
mouse model in some cases does not always completely recapitulate the CHDs observed
in humans due to distinct physiological differences and mouse genetic backgrounds.12 For
example, in mutant mice with one copy of Tbx5, the CHDs that arise accurately reflect
those found in Holt-Oram Syndrome (HOS) patients with a heterozygous mutation of
Tbx5.13 On the other hand, deletion of one copy of Nkx2.5 in mice only recapitulates
some aspects of the CHDs found in humans with an Nkx2.5 deficiency. This indicates
that specific genes may have differing dosage sensitivities between mouse and humans.14
In addition, polymorphisms or mutations of a gene in humans often present as a reduction
in the protein level and/or activity. The associated phenotypes with these human
mutations may not always be accurately reflected in a genetic knockout mouse.11
Furthermore, different genetic modifiers such as epigenetics can influence phenotypical
expression of genetic mutations in differerent mouse strains. For example, mutations in
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Gata4 in the C57BL6/J strain have an increased frequency of CHDs compared to the
FVB/NCrl strain.12 In addition to potential genetic variabilities in mouse models,
differences in physiology such as a shorter gestation time in mouse and a faster heart rate
compared to humans could also influence the phenotypes that arise in mouse mutants.9
Overall, the use of mouse models will continue to be a vital tool in medical research but
their inherent limitations must be considered when they are employed to study CHDs.
Conventional gene targeting, where a specific gene is completely ablated in all
cells of a mouse, has been a critical genetic tool to elucidate gene function. However,
approximately 30% of these knockout mice are embryonic lethal or have early postnatal
lethality, which precludes analysis at later time points.15 To avoid this issue, the Cre/loxP
system has been used extensively to allow spatial control of genetic deletions. Lox/P
sequences flank a critical gene region and act as recognition sites for Cre recombinase,
which is under regulatory control of a tissue specific promoter. The Rac1 knockout
mouse is embryonic lethal,16 therefore the Cre/loxP system was used extensively
throughout this thesis to specifically delete Rac1 in the anterior SHF and the ventricular
myocardium. The heart is comprised of different progenitors that give rise to numerous
cell types including cardiomyocytes, fibroblasts, epicardial cells and endothelial cells.
The use of the Cre/loxP system allows tracking, isolation and characterization of specific
cardiac progenitors and their derivatives, thus facilitating our understanding of heart
development.11 However, the Cre/loxP system does present with potential limitations that
must be considered. Some studies have reported Cre recombinase toxicity in transgenic
mice. There have also been reports of phenotypical abnormalities and altered gene
expression at the sites surrounding Cre insertion. To reduce the potential of Cre toxicity,
the transgene should stay as a single copy as it is passed onto future generations.17-19
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Another issue with the Cre/loxP system is expression of Cre in other unintended tissues.
With Cre driven lineage tracing, a reporter gene (ex. GFP, lacZ) is expressed once the
gene controlling Cre expression is turned on. All daughter cells derived from the first cell
expressing the Cre will also be labeled. However, this may not be a true lineage tracing
of a progenitor cell since any cell type with that particular Cre-controlling gene expressed
will also be labeled. For example, the Isl1-Cre mouse has been used to study the SHF.
However, the Isl1-Cre transgene is also expressed in tissues outside of the cardiac
progenitor population, including motor neuron cells and the dorsal root ganglia.20
Recently, a study showed that Isl1-Cre also marks a subset of cardiac neural crest cells,
revealing a need for more specific cardiac progenitor markers or the use of multiple or
alternative tissue-specific Cre drivers within a study. The anterior SHF Mef2c-Cre
transgene was found to not overlap with cardiac neural crest cells.21
Another issue with some Cre/loxP mouse models is whether the Cre is transmitted
from the male or female parent. In this study with the Mef2c-Cre transgenic mouse, the
Cre was always inherited from the male parent. The Mef2c-Cre is also active in the
female germline and female inheritance would have led to full body expression of Cre
recombinase in the offspring. Moreover, another potential limitation to the Cre/loxP
system is that some floxed sequences may be more easily recombined than others based
on the distance between loxP sites and chromatin state of the loxP sites.22 In this study,
the same line of Rac1f/f and mT/mG transgenic mice were used for all experiments,
therefore the efficiency of recombination should be similar for all samples. Another
limitation to the Cre/loxP system is the inability to control the level or efficiency of Cre
activity. For example, the Mef2c-Cre transgenic mouse was able to sufficiently
downregulate Rac1 expression by 51% while the Nkx2.5-Cre mouse was only able to do
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so by 35%. This inability to control the level of Cre activity can be a limitation when
trying to recapitulate CHDs based on human genetic mutations that present with dosage
sensitivities. Nevertheless, despite the inability to regulate Cre efficiency, the phenotypes
shown using the Cre/loxP system with the Mef2c-Cre and Nkx2.5-Cre transgenic mouse
in this thesis allowed us to elucidate the role of Rac1 in embryonic heart development,
furthering our basic understanding of the mechanisms that could underly CHDs that arise
in humans. Whether human patients have deficiencies in Rac1 expression and/or activity
that lead to development of CHDs remains to be determined.

5.2.2 Use of in vitro cell culture systems
In Chapter 2 of this thesis, in vitro cell cultures and explants were used to
understand the role of Rac1 in cardiomyocyte polarity. Specifically, E12.5 RV from
Rac1SHF;mT/mG and littermate controls were explant cultured onto collagen to study
migration of GFP+ SHF-derived cells. This allowed us to visualize and monitor the
migratory ability of SHF-derived cells in a live manner. In addition, primary
cardiomyocytes from WT hearts were isolated and treated with Ad-Rac1N17 to study
lamellipodia formation after a scratch injury. Primary cardiomyocytes from P0 Rac1SHF
RV were also cultured to analyze cellular characteristics such as length and shape. All of
these in vitro techniques allowed us to examine the role of Rac1 in cardiomoycte polarity
and embryonic heart development, which would have been difficult to do in the in vivo
model. A limitation to the use of in vitro cell cultures is that it does not fully simulate the
in vivo environment that the cells would normally reside in. Cells in an in vivo model are
under constant nourishment from the surrounding blood vessels, have interactions with
other cardiac cell types in a 3D environment and undergo biomechanical forces due to the
beating movements of the heart, which cannot be fully replicated in the in vitro setting.
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Furthermore, use of the adenovirus, Ad-Rac1N17, to knock down Rac1 expression in WT
primary cardiomyocyte cultures likely does not replicate the deficiency in Rac1
expression found in Rac1SHF hearts. However, culture of WT cardiomyocytes was
necessary since primary culture of cardiomyocytes from Rac1SHF RV did not form a
confluent cell layer to facilitate a scratch assay due to the inability of many of the
Rac1SHF cardiomyocytes to adhere to the culture plate. Despite the limitations that in vitro
cultures present, use of these techniques in this thesis were crucial to help further
delineate the specific role of Rac1 in cardiac progenitor migration and cardiomyocyte
polarity during cardiac development. Overall, these in vitro experiments act as supporting
data for the in vivo findings in Chapter 2.

5.3 Suggestions for Future Research
This thesis demonstrated a critical role for Rac1 in embryonic heart development,
specificially in cardiomyocyte polarity, SHF progenitor cellular organization and
development of the OFT and ventricular myocardium. However, some aspects of Rac1
signaling should be investigated in future studies to gain a further understanding of the
role of Rac1 in cardiogenesis.
In Chapter 2 and Chapter 4 of this thesis, I showed that a deficiency in Rac1
leads to defects in ventricular myocardium development. The trabeculation of Rac1SHF
RV and Rac1Nkx2.5 RV and LV are poorly formed and the compact myocardium is thinner
compared to littermate controls. It would be of interest to study cardiac conduction
system development in these hearts as well. Parts of the conduction system are derived
from the embryonic myocardium that retain a primitive phenotype while the surrounding
myocardial cells developing into ventricular myocardium.23 Therefore, I would predict
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that defects in ventricular myocardium development would likely lead to defects in
cardiac conduction system development as well. Cardiac neural crest cells have been
shown to have a role in the development and maturation of the conduction system.
Ablation of cardiac neural crest cells in chick embryos result in noncompaction of the
conduction system bundles.24 In mouse lineage tracing studies, cardiac neural crest cells
have been shown to contribute to formation of the cardiac conduction system.25 In
addition, SHF progenitors have also been demonstrated to contribute to development of
the cardiac conduction system. The sinal atrial node and conduction system of the RV are
derived from the SHF, along with a small subset of cells in the atrial-ventricular node,
His Bundle and left bundle branches.26 Whether Rac1 plays a role in development of the
cardiac conduction system remains to be determined. Future studies using the Rac1SHF
mouse to study the conduction system would be particularly interesting since I would
predict the conduction system to be malformed in the RV. Furthermore, since cardiac
neural crest cells also contribute to the conduction system, the LV conduction system
may also be defective in Rac1SHF hearts. However, whether SHF cells signal to cardiac
neural crest cells through semaphorin-plexin signaling during conduction system
development is currently unknown.
In addition to the cardiac conduction system, development of the coronary arteries
could also be analyzed in future studies. The defects observed in myocardium
development in Chapter 2 and Chapter 4 likely lead to defects in coronary artery
formation as well. Coronary artery development depends on complex crosstalk signaling
between the epicardium and the myocardium, mediated in part by growth factors
including fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and
angiopoietin signaling.27 Whether this crosstalk signaling and coronary artery formation
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is also disrupted in Rac1

Nkx2.5

and Rac1

SHF

hearts remains unknown. Interestingly,

disruption of the PCP pathway in homozygous Looptail (Lp) mutant mice displayed
defects in coronary artery development, despite the lack of expression of Vangl2 in the
epicardium and epicardial-derived cells. Thus, the coronary artery defects were attributed
to abnormal development of the adjacent myocardial cells.28
In Chapter 3, I showed that loss of Rac1 in SHF progenitors in Rac1SHF hearts
also lead to defects in aortic valve maturation and remodeling. P0 Rac1SHF aortic valves
are thickened with a reduced cell density compared to littermate controls, which have thin
elongated aortic valve leaflets. Aortic valve development involves ECM remodeling and
Rac1 has been shown to regulate the ECM remodeling process in the eye and the knee.2931

Whether Rac1 plays a similar role during the process of aortic valve development and

remodeling in cardiogenesis is unknown. Future studies could use specific Cre
recombinase transgenic mice that target specific cells in the valves to study the role of
Rac1, such as the endothelial Tie2-Cre mouse.32
In Chapter 2, I showed that expression of some key cardiac transcription factors
were downregulated in the E12.5 Rac1SHF RV. Rac1 has been shown to promote gene
expression through NF-κB and/or JNK signaling.33, 34 Another study has shown that Rac1
promotes nuclear accumulation of β-catenin in the canonical Wnt pathway.35 Whether
Rac1 acts through these above mentioned pathways or others to regulate gene expression
should be determined in future studies. Furthermore, it would be of interest to determine
whether the same cardiac transcription factors that are downregulated in Rac1SHF hearts
are also downregulated in Rac1Nkx2.5 hearts from Chapter 4. The developing RV and LV
have distinct gene regulatory programs. For example, the transcription factor Hand1 is
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mostly expressed in the in the LV and loss of Hand1 results in LV defects and
dysregulation of downstream gene expression. The transcription factor Hand2 is mostly
expressed in the SHF and loss of Hand2 results in RV defects, along with defects in the
OFT.36 Although Hand1 and Hand2 have partially overlapping roles in ventricular
development, their individual expression patterns in the developing heart suggests
existence of a distinct gene regulatory program between the RV and LV.8 Therefore,
whether loss of Rac1 in the LV of Rac1Nkx2.5 hearts lead to dysregulation of the same
genes in the Rac1Nkx2.5 RV should be further studied.
Rac1, along with other Rho GTPases, have a tight spatio-temporal level of
regulation. For example, loss of Rac1 in embryonic hematopoietic stem cells does not
affect proliferation rate, in contrast to adult hematopoietic stem cells, where the
proliferation rate is decreased.37, 38 In Chapter 2 of this thesis, which used the Rac1SHF
mouse, Rac1 was found to regulate cell survival in the ventricular myocardium at E11.5
and no differences were observed in proliferation rate of the myocardium. However, at an
earlier developmental time point in Chapter 4, which used the Rac1Nkx2.5 mouse, Rac1
was found to regulate proliferation of the E9.5 ventricular myocardium with no effect on
cell apoptosis. Proliferation of the mouse heart is highest at E9.5 and will gradually
decrease as development proceeds.39 Our results suggest a temporal regulation of Rac1
control of proliferation in the ventricular myocardium, where Rac1 plays a critical role
during the highest growth rate at E9.5. Although proliferation of the ventricular
myocardium continues, Rac1 does not seem to play a critical role by E11.5. Similarly,
Rac1 control of cell survival also seems to be regulated in a temporal manner in the
ventricular myocardium. However, whether the temporal differences observed in this
thesis were due to differences in the level of Rac1 downregulation remain to be
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determined. Specifically, in Chapter 2, the Mef2c-Cre transgenic mouse was used while
in Chapter 4, the Nkx2.5-Cre mouse was used, and differences in Cre recombinase
activity likely exist between these two transgenic mouse lines. To definitively determine
the temporal pattern of Rac1 activity, the same Cre recombinase transgenic mouse should
be used for analysis. In addition, a tamoxifen inducible Cre transgenic mouse could be
used to delete Rac1 at specific developmental time points. Lastly, further studies will be
necessary to determine the upstream signals, such as growth factors, hormones, cytokines
and/or adhesion molecules that temporally regulate Rac1 in development of the heart.
Finally, in Chapter 4, proliferation was significantly decreased in the Rac1Nkx2.5
ventricular myocardium. However, the specific mechanisms that Rac1 act through to
regulate proliferation during cardiac development is unclear. Rac1 signals through NF-κB
to regulate cyclin D1, the cell cycle regulator.40 Furthermore, the D-type cyclins have
been shown to be critical regulators of cardiomyocyte proliferation during normal heart
development.41 Future studies will be performed to determine whether this is the pathway
that Rac1 acts through to regulate cardiomyocyte proliferation.

5.4 Conclusion
This thesis is the first to provide evidence of a critical role for Rac1 signaling in
embryonic heart development. Here I demonstrated the importance of Rac1 signaling in
cardiomyocyte polarity, development of OFT and cardiac septum, and formation of the
ventricular myocardium. Deficient Rac1 signaling disrupts several developmental
pathways including proliferation, cell survival, gene expression and actin dynamics,
leading to a spectrum of CHDs including a bifid apex, ASDs, VSDs, OFT defects and
ventricular myocardium defects. While further research is required to determine whether
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Rac1 mutations are involved in human patients with CHDs, this thesis provides evidence
that abberrant Rac1 signaling may underly some cases of this disease. In addition to
potential mutations in the Rac1 gene in humans, abberant signaling of this pathway may
also be due to mutations in the GEFs and GAPs that regulate Rac1. For example,
mutations in the GEF, Son of sevenless homolog 1 (Sos1) is found in 10-15% of Noonan
syndrome patients, who present with a range of developmental defects including
CHDs.42-44 Sos1 acts as a bifunctional GEF for Ras and Rac and a missense mutation in
E846K leads to constitutive activation.45 A study using a mutant mouse model of Noonan
syndrome showed CHDs along with other birth defects, which could be ameliorated with
prenatal administration of a MEK inhibitor.46 Whether this type of treatment can be
applied to human patients should be further studied. Overall, the work in this thesis has
provided valuable insight into the mechanisms by which Rac1 regulates cardiomyocyte
polarity and embryonic heart development. My research has broadened our understanding
of the developmental mechanisms regulated by Rac1 and may have implications in future
diagnosis or treatment of CHDs.
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